Seropositive rheumatoid arthritis, strict definition

RHEUMA_SEROPOS_STRICT

Felty's syndrome: Felty syndrome (FS), also known as ''super rheumatoid'' disease, is a severe form of rheumatoid arthritis (RA), characterized by a triad of RA, splenomegaly and neutropenia, resulting in susceptibility to bacterial infections.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions RHEUMA_SEROPOS_OTH_ICD10	12111
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — ANY KELA reimbursements: ICD-10 — M05 1 out of 7 registries used, show all original rules.	6515
4. Check minimum number of events None	6515
5. Include endpoints None	6515
6. Filter based on genotype QC (FinnGen only)	6358

Control definitions (FinnGen only)

Control conditions: not RHEUMA_SEROPOS_OTH_ICD10

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	RHEUMA_SEROPOS_STRICT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RHEUMA_SEROPOS_OTH_ICD10
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	RHEUMA_SEROPOS_OTH_ICD10
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	ANY
KELA_REIMB_ICD	M05
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Seropositive rheumatoid arthritis, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31325	21200	9976
Only index persons	29603	20324	9279
Unadjusted period prevalence (%)
Whole population	0.50	0.61	0.28
Only index persons	0.62	0.75	0.35
Median age at first event (years)
Whole population	59.60	59.01	60.86
Only index persons	59.06	58.50	60.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6358	4422	1936
Unadjusted period prevalence (%)	1.36	1.57	0.89
Median age at first event (years)	57.08	55.42	60.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6515: Matched controls
65150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZX140

NOMESCO Finland

Intra articular

18.8

322.8

257

142

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

9.2

315.6

394

454

L04AA17

ATC

[U] adalimumab

210.8

307.7

263

L04AX03

ATC

methotrexate; systemic

209.5

307.7

5782

2364

L04AB06

ATC

golimumab; parenteral

44.9

307.7

385

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

18.7

307.7

736

441

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

25.9

307.7

299

121

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

85.8

307.7

2261

401

L04AC07

ATC

tocilizumab; parenteral

120.0

307.7

276

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

63558.4

307.7

6370

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

18.3

307.7

449

262

H02AB07

ATC

prednisone; oral

3.6

307.7

1580

5326

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

1582.0

307.7

2269

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

13.8

307.7

387

297

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

307.7

3834

22406

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

79.1

307.7

1958

352

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

20.4

307.7

286

146

H02AB06

ATC

prednisolone; systemic

9.6

307.7

5498

23412

NDG30

NOMESCO Finland

Fusion of wrist, total

62.2

307.7

234

M06

ICD-10 Finland

Other rheumatoid arthritis

70.8

307.7

336

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

+∞

307.7

6515

2863

M13.9

ICD-10 Finland

Arthritis, unspecified

6.0

307.7

1212

2406

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

8.7

307.7

1903

2939

L04AA24

ATC

abatacept; parenteral

248.6

307.7

462

L88

ICPC

Rheumatoid/seropositive arthritis

62.9

307.7

2546

658

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

37.3

307.7

282

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

12.3

307.7

471

410

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

417.0

307.7

899

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.3

307.7

4194

16675

L04AB05

ATC

certolizumab pegol; parenteral

84.1

307.7

274

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

44.9

307.7

556

135

M01CB03

ATC

auranofin; oral

50.7

307.7

300

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

135.6

307.7

371

WZA10

NOMESCO Finland

Extensive medical or dental certificate

13.1

307.7

327

262

L04AA29

ATC

[U] tofacitinib

74.8

307.7

203

L04AB01

ATC

etanercept; parenteral

83.3

307.7

1160

169

L04AB04

ATC

adalimumab; parenteral

36.6

307.7

1045

338

L04AA13

ATC

[U] leflunomide

92.3

307.7

1856

280

L04AA01

ATC

[U] ciclosporin

18.2

307.7

391

228

L04AA11

ATC

[U] etanercept

91.1

307.7

237

XX9XE

NOMESCO Finland

Other ultrasound examination

19.0

307.7

272

149

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

61.8

307.7

373

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

8.8

307.7

775

985

R4120

NOMESCO Finland

Occupational therapy

4.7

307.7

885

2087

M01CB01

ATC

sodium aurothiomalate; parenteral

160.9

307.7

890

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

48.4

307.7

717

166

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

39.9

307.7

3316

1648

291

Kela drug reimbursment

Tofacitinib

102.5

307.7

218

NDL52

NOMESCO Finland

Tenosynovectomy of hand

28.1

307.7

244

3006

Kela drug reimbursment

Baricitinib

235.2

307.7

227

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

41.8

307.7

3365

1625

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

12.1

307.7

2322

2861

L01BA01

ATC

methotrexate; systemic

69.4

307.7

2218

481

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

15.3

307.7

646

464

NH3EA

NOMESCO Finland

Feet X-ray examination with load

16.8

307.7

637

418

P01BA02

ATC

hydroxychloroquine; oral

185.6

307.7

5559

1979

L04AK01

ATC

leflunomide; oral

45.4

307.7

316

TNG10

NOMESCO Finland

Puncture of knee

21.6

307.7

375

184

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

9.6

307.7

499

556

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

21.5

307.7

668

345

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

16.5

307.7

703

473

A07EC01

ATC

sulfasalazine; oral, rectal

78.0

307.7

4482

1790

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

81.3

307.7

2112

382

3005

Kela drug reimbursment

Tofacitinib

58.9

307.6

172

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

58.2

303.3

170

L04AX01

ATC

azathioprine; systemic

5.6

297.5

594

1137

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.1

287.2

871

2347

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

5.6

281.2

567

1094

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

18.0

274.9

223

128

M12.3

ICD-10 Finland

Palindromic rheumatism

62.2

274.5

152

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

41.3

273.5

165

RT272, ,

NOMESCO Finland

49.0

272.5

158

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

17.2

260.1

216

130

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.9

242.5

342

456

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

11.3

231.4

245

224

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

10.6

225.8

250

244

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

44.1

225.7

134

ZX120

NOMESCO Finland

Intravenous

3.3

221.4

976

3344

293

Kela drug reimbursment

Baricitinib

250.5

213.3

218

L04AA37

ATC

[U] baricitinib

318.8

211.9

214

298, ,

Kela drug reimbursment

59.6

209.6

117

3029

Kela drug reimbursment

Upadacitinib

56.7

207.7

117

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

6.3

197.9

343

570

1XC02, ,

NOMESCO Finland

15.1

197.5

175

119

M25.5

ICD-10 Finland

Pain in joint

2.2

195.5

2616

15217

NH3AE

NOMESCO Finland

Feet ultrasound examination

28.0

179.2

121

NDF10

NOMESCO Finland

Synovectomy of wrist

70.3

178.6

M05BA04

ATC

alendronic acid; oral

3.0

177.6

896

3297

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

53.4

175.5

100

L04AA44

ATC

[U] upadacitinib

55.8

175.2

RT310, ,

NOMESCO Finland

83.9

171.7

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

14.1

171.6

158

115

M13.0

ICD-10 Finland

Polyarthritis, unspecified

8.7

167.8

214

252

RT271, ,

NOMESCO Finland

61.5

163.9

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

8.2

161.7

217

272

NG1DA

NOMESCO Finland

X-ray of knees

6.7

161.6

263

409

9522

FHL

Synovectomy

72.6

159.0

RK220, ,

NOMESCO Finland

24.0

155.6

111

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

153.6

768

2801

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

153.2

639

2097

RK210, ,

NOMESCO Finland

30.4

150.7

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

32.1

147.0

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.8

146.2

468

1292

L20

ICPC

Joint symptom/complaint NOS

4.0

144.6

429

1122

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

62.3

144.3

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

33.3

144.0

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

7.2

142.6

215

308

M01AH01

ATC

celecoxib; oral

2.2

132.2

1482

7830

L04AC14

ATC

sarilumab; systemic

228.0

130.4

134

ND1AE

NOMESCO Finland

Wrist ultrasound examination

17.6

130.1

106

R4180

NOMESCO Finland

Podiatric therapy

7.6

129.2

184

247

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

30.4

127.8

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

9.1

126.0

155

174

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.0

125.1

365

942

L01CB

ATC

Podophyllotoxin derivatives

189.5

125.0

130

M05BA07

ATC

risedronic acid; oral

4.1

120.2

346

884

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

118.7

1037

4930

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

118.1

650

2483

H02AB08

ATC

triamcinolone; systemic

18.9

117.8

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

11.3

115.1

121

109

M17.5

ICD-10 Finland

Other secondary gonarthrosis

6.3

113.2

192

311

L04AD01

ATC

ciclosporin; systemic

5.5

112.7

223

419

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.2

112.2

474

1560

M01AH05

ATC

etoricoxib; oral

1.8

111.9

4289

33349

SPAT1202

SPAT

Intra-articular injection

3.9

111.1

342

916

9256

FHL

Synovectomy (knee 9311)

61.6

109.6

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.9

106.6

330

887

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

10.9

106.2

114

106

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

13.1

102.4

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

14.1

101.4

NHG22

NOMESCO Finland

Fusion of subtalar joint

10.5

100.8

111

107

H02AB04

ATC

methylprednisolone; systemic

2.1

100.8

1131

5913

M01AC06

ATC

meloxicam; systemic, rectal

1.8

100.4

2643

18214

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

31.3

99.7

L04AF03

ATC

upadacitinib; oral

40.4

98.8

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.9

98.4

220

460

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

21.1

94.5

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

94.2

712

3159

A02BC02

ATC

pantoprazole; systemic

1.8

93.4

4630

37727

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

46.2

93.4

M19.2

ICD-10 Finland

Other secondary arthrosis

6.0

92.6

166

284

RT171, ,

NOMESCO Finland

25.8

92.2

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

7.4

91.8

133

182

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

89.7

564

2294

NHG82

NOMESCO Finland

Fusion of other tarsal joint

6.4

87.3

145

230

NDG74

NOMESCO Finland

Fusion of first IP joint

20.2

86.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

86.0

1609

9942

L04AF02

ATC

baricitinib; oral

428.2

85.2

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.9

84.6

187

387

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

6.2

82.6

142

233

D06BB04

ATC

podophyllotoxin; topical

3.1

82.2

370

1260

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

80.2

741

3569

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

33.6

78.3

WX204

NOMESCO Finland

Axillary plexus blockaced

3.3

77.5

303

948

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

202.4

77.4

M05BX04

ATC

denosumab; parenteral

2.5

76.9

522

2198

K71

ICPC

Rheumatic fever/heart disease

39.4

76.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

76.1

629

2891

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.4

74.6

125

200

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.8

73.2

229

619

M06.3

ICD-10 Finland

Rheumatoid nodule

153.8

72.1

WX320

NOMESCO Finland

Spinalanesthesy

1.7

71.9

1670

10892

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

15.1

71.6

M05.0

ICD-10 Finland

Felty syndrome

151.7

71.1

R4110

NOMESCO Finland

Physiotherapy

1.7

70.8

1863

12555

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

70.2

222

605

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.9

70.1

208

542

TGC00

NOMESCO Finland

Bronchial lavation

3.7

69.6

229

641

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

12.0

69.5

RS221, ,

NOMESCO Finland

4.9

68.4

152

316

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

11.0

67.6

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

176.9

67.1

M05BA06

ATC

ibandronic acid; systemic

3.8

67.0

209

564

P01BA01

ATC

chloroquine; systemic

10.4

66.8

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

65.3

534

2438

NDG76

NOMESCO Finland

Fusion of DIP joint

6.7

65.2

103

155

RJ410, ,

NOMESCO Finland

10.9

65.2

Z3226

NOMESCO Finland

Physiotherapist

1.8

64.1

1227

7546

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

14.9

63.0

ZZH31

NOMESCO Finland

Bone allograft, small pieces

6.4

62.5

103

162

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

9.1

62.5

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

62.3

256

825

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

15.5

62.3

L11

ICPC

Wrist symptom/complaint

2.1

62.2

643

3222

L04AF01

ATC

tofacitinib; oral

98.2

61.9

M01AH02

ATC

rofecoxib; oral

1.9

61.4

910

5171

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

60.9

278

953

J01FF01

ATC

clindamycin; systemic

1.6

59.6

1768

12185

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

8.1

59.3

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

59.3

362

1446

WZC30

NOMESCO Finland

Teaching

1.8

58.9

1074

6498

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

58.1

1402

9162

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

5.4

58.0

116

220

RJ511, ,

NOMESCO Finland

15.1

57.9

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

20.1

57.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

57.2

356

1435

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

57.1

381

1587

RT350, ,

NOMESCO Finland

22.2

57.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

56.5

2625

19971

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

56.5

974

5790

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

16.1

56.4

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

289.3

56.3

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.1

56.2

160

M01AE02

ATC

naproxen; oral, rectal

1.5

55.9

3583

29137

N02AX02

ATC

tramadol; systemic, rectal

1.5

55.9

2738

21055

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

54.5

2684

20629

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

77.1

54.0

J01DB01

ATC

cefalexin; oral

1.7

53.7

5283

46981

RK250, ,

NOMESCO Finland

7.9

53.6

M01AX01

ATC

nabumetone; oral

2.6

53.4

332

1337

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.7

53.4

174

484

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

53.1

305

1181

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

53.0

669

3595

R2110

NOMESCO Finland

Giving the first information

2.1

52.5

502

2436

RF120, ,

NOMESCO Finland

4.7

52.2

121

261

M01CC01

ATC

penicillamine; oral

74.5

52.1

M01AB55

ATC

diclofenac, combinations; oral

2.2

51.7

491

2376

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

51.6

2843

22277

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.1

51.4

145

364

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

3.6

51.2

169

474

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

262.7

51.2

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

51.0

2877

22631

S18

ICPC

Laceration/cut

1.5

50.8

2875

22626

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.9

50.6

RT274, ,

NOMESCO Finland

16.0

50.3

RJ512, ,

NOMESCO Finland

14.6

50.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

50.0

508

2523

S97

ICPC

Chronic ulcer skin

2.3

49.9

402

1819

318

Kela drug reimbursment

Teriparatide

7.0

49.9

110

N02BE01

ATC

paracetamol; systemic, rectal

1.8

49.2

5769

52830

NDM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand

7.2

49.0

103

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.1

48.6

498

2480

ZXA00

NOMESCO Finland

Right side

1.6

48.5

1694

12021

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

48.5

764

4405

R5120

NOMESCO Finland

Preparation of an aid

2.9

48.3

229

801

H05AA02

ATC

teriparatide; parenteral

7.1

48.2

102

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

47.5

195

628

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

10.5

47.3

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

46.8

224

788

RS222, ,

NOMESCO Finland

4.5

46.1

113

255

M13.8

ICD-10 Finland

Other specified arthritis

4.9

46.0

102

212

NHG20

NOMESCO Finland

Fusion of talocrural joint

6.6

45.8

114

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.9

45.3

218

769

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

45.3

360

1619

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.3

45.1

359

1615

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

44.8

680

3871

L17

ICPC

Foot/toe symptom/complaint

1.5

44.7

1833

13423

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.7

44.3

254

982

L84

ICD-10 Finland

Corns and callosities

2.7

44.3

253

977

QDH05

NOMESCO Finland

Correction of deformity of toe nail

10.3

44.0

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.3

43.9

171

RJ421, ,

NOMESCO Finland

8.0

43.9

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.0

43.4

493

2547

SPAT1229

SPAT

Assessment of need for aid

2.0

43.4

516

2710

L99

ICPC

Musculoskeletal disease other

3.2

43.3

177

569

9531

FHL

Arthrodesis of the hand joint

9.7

43.0

9284

FHL

Wrist ossification surgery

94.7

42.8

9272

FHL

Metatarsophalangeal joint resection

10.1

42.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

42.4

460

2338

M01AX17

ATC

nimesulide; oral

1.5

42.0

1546

11039

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.8

42.0

131

354

L95

ICPC

Osteoporosis

2.4

41.9

294

1251

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

41.6

485

2529

RS121, ,

NOMESCO Finland

6.2

41.6

116

RJ190, ,

NOMESCO Finland

12.6

40.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

40.5

1020

6670

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

9.7

40.3

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

6.9

40.2

L12

ICPC

Hand/finger symptom/complaint

1.6

40.1

999

6515

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

12.7

40.0

NDG20

NOMESCO Finland

Fusion of wrist, partial

6.1

39.9

114

Z3231

NOMESCO Finland

Registered nurse

1.5

39.5

1645

12029

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.8

39.4

120

319

R50.9

ICD-10 Finland

Fever, unspecified

1.7

39.2

876

5555

A02BC03

ATC

lansoprazole; oral

1.5

39.1

1816

13566

RJ411, ,

NOMESCO Finland

6.1

38.7

111

RJ210, ,

NOMESCO Finland

9.8

38.3

RF410, ,

NOMESCO Finland

3.9

38.1

114

299

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

7.1

38.1

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

196.1

37.8

ZXA05

NOMESCO Finland

Left side

1.5

37.6

1517

11005

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

50.3

37.6

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

8.1

37.5

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

55.3

37.3

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.5

37.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

37.2

845

5376

RT231, ,

NOMESCO Finland

191.1

36.8

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

7.4

36.0

RF420, ,

NOMESCO Finland

3.6

35.9

119

335

NC1AE

NOMESCO Finland

Elbow ultrasound examination

13.1

35.7

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

11.3

35.3

NBF15

NOMESCO Finland

Humeroscapular synovectomy, arthroscopic

9.4

35.3

4AA24, ,

NOMESCO Finland

349.2

35.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

34.9

179

654

ZX100

NOMESCO Finland

Oral

3.6

34.7

115

324

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.1

34.2

323

1556

L28

ICPC

Limited function/disability (L)

1.5

34.2

1076

7386

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

4.0

33.9

238

M05.1

ICD-10 Finland

Rheumatoid lung disease

120.7

33.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

33.6

1746

13247

4AB02, ,

NOMESCO Finland

9.6

33.2

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

74.5

32.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

32.6

769

4929

RF212, ,

NOMESCO Finland

7.2

32.6

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.0

31.9

231

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

31.8

2481

20131

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

31.7

737

4704

WW200

NOMESCO Finland

Immunization

2.6

31.5

181

701

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

36.6

31.5

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.4

31.3

225

969

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

30.9

316

1569

NDL99

NOMESCO Finland

Other operation on muscle or tendon of wrist or hand

9.3

30.9

4AC07, ,

NOMESCO Finland

110.6

30.7

ACC51

NOMESCO Finland

Release of median nerve

1.8

30.5

490

2826

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

30.3

233

1033

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.4

30.3

NF1DA

NOMESCO Finland

X-ray of hips

2.7

30.1

159

590

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

3.0

29.7

134

457

9527

FHL

Alloarthroplasty, implant or endoprosthesis

155.7

29.7

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

3.8

29.6

244

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

29.6

283

1371

NDG71

NOMESCO Finland

Arthrodes of first MP joint

8.2

29.5

L34

ICPC

Musculoskeletal, Blood test

37.2

29.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

29.2

421

2350

Z2446

NOMESCO Finland

Social worker

1.9

29.2

372

1996

RK120, ,

NOMESCO Finland

8.5

28.7

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.7

28.7

578

3552

M15.3

ICD-10 Finland

Secondary multiple arthrosis

6.8

28.4

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

10.8

27.8

NH1AD

NOMESCO Finland

Ankle and foot CT

2.6

27.5

157

607

Z71.8

ICD-10 Finland

Other specified counselling

1.4

27.3

1786

14001

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

27.3

634

9594

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

27.2

2137

17245

NHK68

NOMESCO Finland

Shortening or lengthening osteotomy of ankle or foot

5.4

27.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

27.1

457

2674

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.0

26.9

117

391

B01AB05

ATC

enoxaparin; parenteral

1.4

26.8

1903

15108

R3130

NOMESCO Finland

Training in activities of daily lining

272.2

26.7

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

26.6

349

1889

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

3.7

26.6

234

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

26.6

467

2764

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

26.2

110

360

B02.9

ICD-10 Finland

Zoster without complication

1.8

26.2

417

2398

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.8

26.2

134

490

9289

FHL

Other measure in this category

36.9

26.1

Z2221

NOMESCO Finland

Medical doctor

1.4

26.0

1590

12311

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

25.9

179

757

H26.3

ICD-10 Finland

Drug-induced cataract

4.8

25.9

122

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

25.9

701

4632

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

25.5

584

3706

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

25.5

707

4696

M05.2

ICD-10 Finland

Rheumatoid vasculitis

44.5

25.5

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

5.5

25.5

A46

ICD-10 Finland

Erysipelas

1.5

25.4

795

5425

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

4.6

24.9

126

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

24.7

2282

18793

J47

ICD-10 Finland

Bronchiectasis

2.8

24.7

127

466

M50.8

ICD-10 Finland

Other cervical disc disorders

4.9

24.5

112

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

5.2

24.5

A02BB01

ATC

misoprostol; oral

5.1

24.4

101

L01BB01, ,

ATC

9.4

24.4

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

3.2

24.3

303

-1, ,

NOMESCO Finland

1.4

24.3

1812

14449

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

24.3

1079

7890

9283

FHL

Subtalar joint ossification surgery (or triple)

34.6

24.2

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

24.2

301

1601

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

24.1

1706

13491

RJ412, ,

NOMESCO Finland

8.4

24.0

Z50.1

ICD-10 Finland

Other physical therapy

1.9

23.7

325

1785

J99.0

ICD-10 Finland

Rheumatoid lung disease

240.9

23.7

J01MA12

ATC

levofloxacin; systemic

1.4

23.6

1034

7539

M05BX03

ATC

strontium ranelate; oral

4.4

23.3

129

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

22.1

23.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

22.9

316

1738

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.0

22.9

330

J01CA04

ATC

amoxicillin; systemic

1.4

22.7

4972

45881

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

22.6

197

920

M08.8

ICD-10 Finland

Other juvenile arthritis

230.8

22.6

SPAT1255

SPAT

Intravenous administration of medicine

1.7

22.6

392

2310

H16.0

ICD-10 Finland

Corneal ulcer

1.9

22.4

276

1464

5BA08, ,

NOMESCO Finland

5.0

22.3

TNF10

NOMESCO Finland

Puncture of hip joint

7.6

22.1

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

4.0

22.0

152

M05BA01

ATC

etidronic acid; systemic

4.9

22.0

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.4

21.9

144

596

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.4

21.8

148

622

S20

ICPC

Corn/callosity

2.5

21.7

131

521

RF430, ,

NOMESCO Finland

6.5

21.7

H16.9

ICD-10 Finland

Keratitis, unspecified

2.7

21.7

113

418

RS224, ,

NOMESCO Finland

5.4

21.6

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.6

21.6

123

476

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.6

21.3

192

NHQ40

NOMESCO Finland

Amputation of toe

3.1

21.3

286

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

21.3

1295

9974

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

21.2

402

2428

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

21.0

224

1131

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

2.8

20.9

106

386

RF210, ,

NOMESCO Finland

2.2

20.6

173

797

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

20.6

608

4090

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.4

20.5

145

621

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

20.5

5626

53182

QDH

NOMESCO Finland

Operations on toe nails

27.1

20.0

L16

ICPC

Ankle symptom/complaint

1.5

19.7

641

4399

RJ120, ,

NOMESCO Finland

8.2

19.6

WX214

NOMESCO Finland

Plexus blockade at the ankle

4.4

19.6

113

L45

ICPC

Musculoskeletal, Observ/health educat/advice/diet

7.7

19.5

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.8

19.5

339

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

19.5

236

1246

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

5.7

19.4

RF421, ,

NOMESCO Finland

4.3

19.4

114

R5110, ,

SPAT

1.7

19.4

385

2354

A28

ICPC

Limited function/disability NOS

1.4

19.2

913

6735

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

19.2

243

1302

L60

ICPC

Musculoskeletal, Result test/procedure

5.9

19.1

L08

ICPC

Shoulder symptom/complaint

1.4

19.1

1256

9771

M66.2

ICD-10 Finland

Spontaneous rupture of extensor tendons

7.2

19.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

19.0

466

3004

ND2CG

NOMESCO Finland

Extensive MRI of hand

6.2

18.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

18.9

1455

11588

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

18.7

529

3521

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

18.7

698

4923

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

18.6

120

493

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

18.6

1128

8664

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.2

18.5

162

759

M95.8

ICD-10 Finland

Other specified acquired deformities of musculoskeletal system

38.5

18.5

SPAT1153

SPAT

Removal of sutures

1.3

18.5

1827

15045

R60.0

ICD-10 Finland

Localized oedema

1.5

18.5

694

4900

ZXE00

NOMESCO Finland

One hour or less

1.3

18.5

2198

18538

M11.2

ICD-10 Finland

Other chondrocalcinosis

5.2

18.4

J05AB11

ATC

valaciclovir; oral

1.4

18.4

835

6109

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

18.3

360

2194

L88

ICD-10 Finland

Pyoderma gangrenosum

7.5

18.2

SPAT1204

SPAT

Arthrocentesis

3.6

18.1

170

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

18.1

603

4158

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

18.0

122

513

WZA00

NOMESCO Finland

Concise certificate

1.7

18.0

357

2183

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

7.6

17.8

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.3

17.8

132

578

9260

FHL

Alloarthroplasty, endoprosthesis or implant

66.8

17.7

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.2

17.7

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

3.7

17.6

145

GX1K5

NOMESCO Finland

Diffusion capacity

4.3

17.6

106

N02AA05

ATC

oxycodone; systemic

1.4

17.5

937

7046

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

17.5

135

602

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.7

17.4

349

ZXA10

NOMESCO Finland

Bilateral

1.4

17.4

1032

7891

NHF70

NOMESCO Finland

Operation for debridement of joint of foot, open

24.1

17.3

L02BG04

ATC

letrozole; oral

0.5

17.3

150

3007

M70.2

ICD-10 Finland

Olecranon bursitis

2.1

17.2

163

789

M79.6

ICD-10 Finland

Pain in limb

1.3

17.1

2450

21076

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

17.1

648

4582

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

17.0

275

NCF15

NOMESCO Finland

Synovectomy of elbow joint, arthroscopic

31.5

17.0

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

17.0

286

1672

M02AA07

ATC

piroxicam; topical

1.3

16.7

2098

17753

K07.60

ICD-10 Finland

Snapping jaw

1.7

16.6

282

1653

L04AA14

ATC

[U] anakinra

90.3

16.6

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.6

16.5

152

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.5

16.5

100

400

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

16.3

2035

17202

M25.4

ICD-10 Finland

Effusion of joint

2.7

15.9

320

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

15.8

268

1569

RJ420, ,

NOMESCO Finland

4.6

15.8

R06.0

ICD-10 Finland

Dyspnoea

1.3

15.8

1479

12052

C03CA01

ATC

furosemide; systemic

1.3

15.7

1538

12600

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

15.6

176

907

RK221, ,

NOMESCO Finland

85.3

15.6

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

15.5

1690

14035

NCK10

NOMESCO Finland

Partial or total excision of bone of elbow or forearm, other location

13.7

15.5

A01

ICPC

Pain general/multiple sites

1.5

15.4

510

3507

R03AC02

ATC

salbutamol; inhalant

1.2

15.4

3191

28479

J94.9

ICD-10 Finland

Pleural condition, unspecified

4.5

15.4

R4180, ,

SPAT

3.1

15.4

210

A60

ICPC

General and Unspecified, Result test/procedure

1.8

15.3

242

1389

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

15.2

211

1165

A02BA02

ATC

ranitidine; systemic

1.3

15.2

1072

8398

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

3.5

15.2

151

H16.8

ICD-10 Finland

Other keratitis

5.3

15.1

J05AB01

ATC

aciclovir; systemic

1.3

15.1

1232

9852

NDG63

NOMESCO Finland

Arthroplasty of II-V MCP joint

45.1

15.0

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

2.5

15.0

382

RT172, ,

NOMESCO Finland

11.8

15.0

A03

ICPC

Fever

1.4

14.9

823

6213

RF222, ,

NOMESCO Finland

31.8

14.8

RK224, ,

NOMESCO Finland

56.8

14.8

J01FA06

ATC

roxithromycin; oral

1.2

14.7

2288

19772

G63.6*M05.3

ICD-10 Finland

Rheumatoid polyneuropathy

+∞

14.6

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

3.3

14.6

170

115

Kela drug reimbursment

Breast cancer

0.6

14.6

229

3844

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

14.4

300

1857

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

14.4

158

808

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

14.3

946

7336

SPAT1325

SPAT

Vaccination

1.3

14.2

1820

15371

M01AB01

ATC

indometacin; systemic, rectal

1.6

14.2

358

2321

R81

ICPC

Pneumonia

1.9

14.2

190

1038

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.2

694

5131

RF110, ,

NOMESCO Finland

5.3

14.2

M02AA10

ATC

ketoprofen; topical

1.3

14.2

897

6911

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

14.1

2075

17796

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.2

14.1

M06.2

ICD-10 Finland

Rheumatoid bursitis

42.6

14.1

TNC10

NOMESCO Finland

Joint puncture, elbow joint

42.6

14.1

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

2.6

14.0

311

M35.1

ICD-10 Finland

Other overlap syndromes

4.1

14.0

SPAT1251

SPAT

Organisation of medication

1.9

13.9

177

951

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.1

13.9

J01MA14

ATC

moxifloxacin; systemic

1.5

13.8

472

3268

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

53.4

13.8

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.6

13.8

356

2322

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

13.7

1418

11672

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.7

13.6

264

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

13.6

3805

34828

R05

ICD-10 Finland

Cough

1.3

13.6

1187

9563

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

13.6

2576

22676

ZY010

NOMESCO Finland

Hospital outpatient

1.7

13.6

239

1417

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.2

13.5

118

554

I32.8*M05.3

ICD-10 Finland

Pericarditis (in) rheumatoid

+∞

13.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

13.5

1619

13555

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

13.5

975

7652

GX1D5

NOMESCO Finland

Flow volume spirometry

5.9

13.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

13.3

386

2582

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

4.3

13.3

ND2BG

NOMESCO Finland

MRI of hand

5.7

13.2

-50

ICPC

Medication/prescr/renewal

1.7

13.0

214

1245

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

13.0

135

678

WX002

NOMESCO Finland

Sedation and analgesia

1.3

13.0

1058

8441

Z22.30

ICD-10 Finland

Latent tuberculosis

16.7

13.0

NHG70

NOMESCO Finland

Arthroplasty of first tarsometatarsal joint

2.2

12.9

110

513

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.5

12.9

128

NDB20

NOMESCO Finland

Primary total prosthetic replacement of joint of wrist not using cement, all parts

50.1

12.8

NB1AD

NOMESCO Finland

Shoulder CT examination

2.2

12.7

444

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

14.0

12.7

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.8

12.6

174

960

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

12.6

306

1967

H04AA01

ATC

glucagon; nasal, parenteral

2.2

12.6

446

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

12.6

1415

11746

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

12.5

951

7512

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

12.5

154

820

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

12.5

165

899

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

9.3

12.4

ZX114

NOMESCO Finland

Intramuscular

2.5

12.4

319

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

12.3

146

769

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.8

12.2

170

942

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.2

3259

29555

A04AA01

ATC

ondansetron; systemic, rectal

1.5

12.2

447

3139

L04AB02

ATC

infliximab; parenteral

4.4

12.1

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

12.1

121

2314

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

12.1

1307

10795

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

12.1

280

1782

M01AB05

ATC

diclofenac; systemic, rectal

1.2

12.1

3911

36098

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

26.7

12.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

11.9

1599

13529

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

11.9

223

1345

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

11.9

179

1015

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

11.9

844

6601

A10BA02

ATC

metformin; oral

0.8

11.9

1007

12420

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

4.0

11.9

3048, ,

Kela drug reimbursment

46.7

11.9

255, ,

Kela drug reimbursment

46.7

11.9

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.5

11.8

116

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.2

11.7

434

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

11.7

1232

10138

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

11.6

301

1965

M01AE52

ATC

naproxen and esomeprazole; oral

1.8

11.6

181

1039

M75.5

ICD-10 Finland

Bursitis of shoulder

1.9

11.5

133

694

7230B

ICD-9 Finland

Other disorders of cervical region, Spinal stenosis of cervical region[SUBLUXATIO ATLANTO-AXIALIS]

+∞

11.5

G63.6

ICD-10 Finland

Polyneuropathy in other musculoskeletal disorders

+∞

11.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

11.4

234

1445

SFA10

NOMESCO Finland

One-surface restoration

1.2

11.3

3069

27788

SPAT1301

SPAT

No procedures

1.2

11.3

1675

14313

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

2.5

11.2

262

R05

ICPC

Cough

1.3

11.2

1296

10780

M02.8

ICD-10 Finland

Other reactive arthropathies

3.8

11.2

L15

ICPC

Knee symptom/complaint

1.3

11.2

1311

10920

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

2.0

11.1

111

550

A10AA01, ,

ATC

2.0

11.1

122

626

N03AX16

ATC

[U] pregabalin

1.3

11.0

1287

10709

M79.7

ICD-10 Finland

Fibromyalgia

1.7

11.0

200

1197

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.2

11.0

439

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

11.0

2909

26254

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

5.0

11.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

11.0

105

513

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.0

10.9

118

602

E0000UV, ,

ATC

1.2

10.9

2302

20347

ND1DA

NOMESCO Finland

Bilateral wrist X-ray examination

43.4

10.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.8

355

2439

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

10.8

229

1428

B01AX06

ATC

[U] rivaroxaban

1.9

10.8

124

647

Z01.2

ICD-10 Finland

Dental examination

1.2

10.7

2491

22205

J01AA02

ATC

doxycycline; systemic

1.2

10.7

4721

44578

NDB70

NOMESCO Finland

Prosthetic replacement of one IP joint

12.9

10.6

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

60.1

10.6

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

10.6

381

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

1.6

10.6

215

1326

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

3.4

10.5

110

A02BC05

ATC

esomeprazole; systemic

1.2

10.5

2337

20737

NGB30

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis

3.3

10.5

120

RD211, ,

NOMESCO Finland

1.6

10.5

228

1430

1008, ,

NOMESCO Finland

9.2

10.5

WX213

NOMESCO Finland

Lower leg blockade

2.9

10.5

162

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.1

10.4

462

K07

ICPC

Swollen ankles/oedema

1.6

10.4

233

1471

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

10.4

205

1254

RT340, ,

NOMESCO Finland

110.2

10.4

NCC30

NOMESCO Finland

Secondary implantation of prosthesis in elbow joint, two parts

+∞

10.4

K08.3

ICD-10 Finland

Retained dental root

1.5

10.4

374

2618

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.5

10.3

261

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.4

10.3

304

0108, ,

NOMESCO Finland

23.4

10.2

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

10.2

121

638

M45

ICD-10 Finland

Ankylosing spondylitis

2.1

10.2

460

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

10.1

356

ZZH22

NOMESCO Finland

Graft of patients own bone, block

3.5

10.1

RS211, ,

NOMESCO Finland

4.2

10.1

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

10.1

464

3395

M81.8

ICD-10 Finland

Other osteoporosis

2.5

10.0

258

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.9

10.0

155

T84.4

ICD-10 Finland

Mechanical complication of other internal orthopaedic devices, implants and grafts

4.8

10.0

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.1

10.0

417

TEA00

NOMESCO Finland

Biopsy of lip

2.5

10.0

235

L04AA45

ATC

[U] filgotinib

40.1

10.0

9526

FHL

Autoarthroplasty (eg Vainio)

40.1

10.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

9.9

293

1970

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

2.9

9.9

156

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.8

9.9

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.0

9.9

135

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.8

9.9

147

833

TND11, ,

SPAT

7.6

9.9

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

9.9

103

520

TNH11, ,

SPAT

12.2

9.8

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

2.2

9.7

337

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.6

9.7

203

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

9.7

256

1681

RF220, ,

NOMESCO Finland

2.2

9.7

331

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

9.7

4102

38370

RF310, ,

NOMESCO Finland

3.7

9.7

N07BA03

ATC

varenicline; oral

1.6

9.7

221

1404

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

7.4

9.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

9.6

1095

9072

M01AB08

ATC

etodolac; oral

1.4

9.6

384

2740

M20.5

ICD-10 Finland

Other deformities of toe(s) (acquired)

2.7

9.6

187

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

1.9

9.6

112

588

RF433, ,

NOMESCO Finland

7.8

9.6

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

9.6

451

RJ414, ,

NOMESCO Finland

5.0

9.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.8

9.6

879

10766

ZXX07

NOMESCO Finland

Extent of procedure, 7 units

11.4

9.5

ZZH20

NOMESCO Finland

Graft of patients own bone

3.6

9.5

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

4.0

9.5

J94.8

ICD-10 Finland

Other specified pleural conditions

2.2

9.4

367

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.9

9.4

111

585

RJ126, ,

NOMESCO Finland

7.5

9.4

SPAT1260

SPAT

Consultation of another employee

1.3

9.4

916

7455

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

9.4

2097

18572

QDB10, ,

SPAT

2.1

9.4

408

B01AF01

ATC

rivaroxaban; oral

1.3

9.3

657

5129

A10AB01

ATC

insulin (human); parenteral

1.7

9.3

150

871

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

9.3

264

1763

L29

ICPC

Musculoskeletal sympt/complt other

1.4

9.3

436

3201

RF214, ,

NOMESCO Finland

8.7

9.3

ZZH40

NOMESCO Finland

Substitute of bone

2.5

9.2

232

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

9.2

231

1500

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

3.8

9.2

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

9.1

239

3562

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

9.1

382

2751

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

2.8

9.1

153

R03BB04

ATC

tiotropium bromide; inhalant

1.4

9.0

478

3577

RK260, ,

NOMESCO Finland

9.0

NGF10

NOMESCO Finland

Total synovectomy of knee, open

7.0

9.0

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

7.0

9.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

9.0

590

4561

QDH00

NOMESCO Finland

Avulsion of toe nail

4.1

9.0

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.2

8.9

343

I00

ICD-10 Finland

Rheumatic fever without mention of heart involvement

24.0

8.9

XA402

NOMESCO Finland

ENMG

1.8

8.9

128

719

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

8.9

173

1057

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

3.3

8.9

B01AB04

ATC

dalteparin; parenteral

1.5

8.8

255

1708

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

12.5

8.8

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

8.8

200

1269

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

8.8

3110

28553

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.1

8.8

391

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

8.8

123

686

-55

ICPC

Local injection/infiltration

2.8

8.7

157

L04AF04

ATC

filgotinib; oral

50.1

8.7

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

1.9

8.7

104

552

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

8.6

1841

16209

SPAT1254

SPAT

Administration of medicine

1.3

8.6

697

5539

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

8.6

673

5326

4AA12, ,

NOMESCO Finland

4.8

8.6

SPAT1263

SPAT

Sampling

1.2

8.6

2254

20198

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

2.9

8.6

136

WX111

NOMESCO Finland

Local infiltration anesthesia

1.6

8.6

185

1161

RJ530, ,

NOMESCO Finland

16.3

8.5

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

6.9

8.5

ZZH32

NOMESCO Finland

Bone allograft, block

9.0

8.5

A02BC01

ATC

omeprazole; systemic

1.2

8.5

1460

12602

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

2.9

8.5

137

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

8.4

391

SPAT1252

SPAT

Overall medication plan or its review

1.4

8.4

326

2314

RD210, ,

NOMESCO Finland

2.0

8.4

398

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

8.4

154

9513

FHL

Reconstruction of the tendon sheath or plump

90.2

8.4

M14

ICD-10 Finland

Arthropathies in other diseases classified elsewhere

+∞

8.3

NCC20

NOMESCO Finland

Secondary implantation of prosthesis in elbow joint, one part

+∞

8.3

S42.4

ICD-10 Finland

Fracture of lower end of humerus

2.3

8.3

244

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

8.3

101

1814

NHG88

NOMESCO Finland

Fusion of several tarsal joints

9.4

8.3

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.7

8.2

149

894

N05BA04

ATC

oxazepam; oral

0.8

8.2

1002

11920

H02AB02

ATC

dexamethasone; systemic

0.7

8.2

354

4817

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

6.5

8.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

8.1

768

6222

S70

ICPC

Herpes zoster

1.7

8.1

138

815

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.1

412

3066

4AB0X, ,

NOMESCO Finland

33.4

8.1

NDL32

NOMESCO Finland

Suture or reinsertion of tendon of wrist or hand, extensor tendon

2.4

8.0

211

TNA11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, back or neck

22.0

8.0

9508

FHL

Tendon or muscle transposition

22.0

8.0

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.7

8.0

147

B35.3

ICD-10 Finland

Tinea pedis

1.6

8.0

200

1301

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

3.8

8.0

M71.9

ICD-10 Finland

Bursopathy, unspecified

2.3

7.9

262

J01DA01

ATC

[U] cefalexin

1.2

7.9

3524

32826

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.0

7.9

415

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.8

605

4781

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

1.8

7.8

105

579

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

7.8

171

1080

S01XA18

ATC

ciclosporin; ophthalmic

2.5

7.7

179

NHF10

NOMESCO Finland

Synovectomy of ankle, open

45.0

7.7

SPAT1216

SPAT

Assessment of functional ability

1.3

7.7

771

6288

K11.7

ICD-10 Finland

Disturbances of salivary secretion

6.3

7.7

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.5

7.7

1332

C07AA05

ATC

propranolol; systemic

0.8

7.7

725

8869

S01AD03

ATC

aciclovir; ophthalmic

1.6

7.7

174

1107

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

7.7

493

6325

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

2.3

7.6

248

M48.0

ICD-10 Finland

Spinal stenosis

1.3

7.6

610

4846

-60

ICPC

Result test/procedure

1.4

7.6

275

1932

NHW10

NOMESCO Finland

Reoperation for deep infection in in surgery of ankle or foot

6.1

7.5

S73.0

ICD-10 Finland

Dislocation of hip

2.8

7.5

135

9252

FHL

Plaster bandage placement or replacement (no fracture) in the operating room

10.0

7.5

TEG00

NOMESCO Finland

Punction of mandibular joint

7.1

7.5

ZYC01

NOMESCO Finland

Remote contact by phone

1.4

7.4

274

1930

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.7

7.4

250

3549

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

3.9

7.4

NBF10

NOMESCO Finland

Humeroscapular synovectomy, open

80.2

7.4

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

7.4

268

1881

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.3

7.4

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

7.4

113

649

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.9

7.3

447

J01FA10

ATC

azithromycin; systemic

1.2

7.3

3208

29772

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

7.3

138

839

TNX10, ,

SPAT

2.5

7.3

178

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.3

505

3933

R76.0

ICD-10 Finland

Raised antibody titre

3.6

7.3

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

7.3

130

779

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.6

7.3

157

2434

SPAT1211

SPAT

Application of soft bandage

1.3

7.2

415

3147

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

2.1

7.2

319

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.2

1389

12091

S72.2

ICD-10 Finland

Subtrochanteric fracture

2.7

7.2

138

TNH10, ,

SPAT

15.7

7.2

A55

ICPC

General and Unspecified, Local injection/infiltration

2.3

7.2

241

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.2

4096

38709

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

7.2

1461

12778

J01XX08

ATC

linezolid; systemic

2.9

7.2

116

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

7.2

308

2229

N05AH04

ATC

quetiapine; oral

0.8

7.2

544

6832

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

0.6

7.1

115

1910

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

7.1

296

2131

NDG79

NOMESCO Finland

Other excision, reconstruction or fusion of joint of II-V finger

6.6

7.1

RT360, ,

NOMESCO Finland

7.9

7.1

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

2.0

7.1

376

ZZA00

NOMESCO Finland

Split skin graft

1.7

7.1

125

747

K02.2

ICD-10 Finland

Caries of cementum

1.5

7.1

214

1451

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

7.1

1600

14118

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.1

1515

13308

B82

ICPC

Anaemia other/unspecified

1.7

7.0

123

733

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

7.0

522

4103

NDF20

NOMESCO Finland

Operation for osteochondritis of joint of wrist, open

8.8

7.0

T89

ICPC

Diabetes insulin dependent

1.6

7.0

164

1051

RJ516, ,

NOMESCO Finland

10.0

7.0

SFA30

NOMESCO Finland

Three-surface restoration

1.2

7.0

2294

20827

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.9

7.0

448

N05AH03

ATC

olanzapine; systemic

0.6

7.0

111

1850

J04AB02

ATC

rifampicin; systemic

2.1

7.0

277

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

7.0

1164

10003

A10AA02, ,

ATC

1.7

7.0

133

812

L01AA02

ATC

chlorambucil; oral

4.4

6.9

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.2

6.9

258

C10AA07

ATC

rosuvastatin; oral

0.8

6.9

1352

15423

A04AA55

ATC

palonosetron, combinations; systemic

0.5

6.9

1311

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

0.4

6.9

778

M43.3

ICD-10 Finland

Recurrent atlantoaxial subluxation with myelopathy

13.8

6.9

NH1DA

NOMESCO Finland

Bilateral ankle X-ray examination

13.8

6.9

L01AA01

ATC

cyclophosphamide; systemic

3.6

6.9

L70

ICPC

Infection of musculoskeletal system

3.1

6.8

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.8

2045

18435

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

2.5

6.8

166

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.5

6.8

197

1324

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

8.3

6.8

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.0

6.8

320

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.8

1789

15968

ND1DG

NOMESCO Finland

Wrist and hand very extensive MRI examination with high intensity magnet

4.1

6.8

A98

ICPC

Health maint/preventive medicine

1.3

6.8

6140

60235

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

6.8

960

8120

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

6.8

170

1108

S72.3

ICD-10 Finland

Fracture of shaft of femur

2.3

6.8

197

G57.6

ICD-10 Finland

Lesion of plantar nerve

1.7

6.7

116

689

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.8

6.7

534

D64.8

ICD-10 Finland

Other specified anaemias

1.9

6.7

419

NDT99

NOMESCO Finland

Other operation on wrist or hand

7.2

6.7

N05AH02

ATC

clozapine; systemic

0.2

6.7

369

H3600, E103,

ICD-10 Finland

2.3

6.7

205

M01AH03

ATC

valdecoxib; oral

1.4

6.6

300

2193

B01AF02

ATC

apixaban; oral

1.3

6.6

589

4740

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.7

6.6

122

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.5

6.6

1380

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.6

2010

18137

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

6.6

112

664

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

6.6

429

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

6.6

1184

10242

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.6

6.6

133

825

KMAK, ,

NOMESCO Finland

1.1

6.5

2775

25621

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.0

6.5

J12.8

ICD-10 Finland

Other viral pneumonia

2.4

6.5

182

B80

ICPC

Iron deficiency anaemia

1.7

6.5

111

658

-44

ICPC

Preventive immunization/medic

1.3

6.5

388

2960

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

1.9

6.5

416

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

6.5

1146

9891

RK110, ,

NOMESCO Finland

2.5

6.5

146

J86.9

ICD-10 Finland

Pyothorax without fistula

2.5

6.5

152

B02

ICD-10 Finland

Zoster [herpes zoster]

1.5

6.5

211

1453

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.0

6.5

299

NDU00

NOMESCO Finland

Removal of prosthesis from wrist

69.9

6.4

S55

ICPC

Skin, Local injection/infiltration

3.5

6.4

C50

ICD-10 Finland

Malignant neoplasm of breast

0.5

6.4

920

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.3

6.4

391

2995

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.0

6.4

308

N05AX08

ATC

risperidone; systemic

0.7

6.4

181

2648

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.2

6.4

235

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

3.7

6.4

GX2C5

NOMESCO Finland

Short-lasting oximetry

2.9

6.3

102

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.5

6.3

148

9271

FHL

Hallux surgery

1.7

6.3

106

626

SBB10

NOMESCO Finland

Dental impressions

1.4

6.3

270

1957

RF431, ,

NOMESCO Finland

11.0

6.3

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

9.2

6.3

TQX00

NOMESCO Finland

Needle biopsy of skin

9.2

6.3

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

0.6

6.3

1424

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

3.2

6.3

QXB05, ,

SPAT

2.5

6.3

143

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

6.2

372

2841

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.3

6.2

180

N06AB10

ATC

escitalopram; oral

0.8

6.2

710

8518

I50.0

ICD-10 Finland

Congestive heart failure

1.4

6.2

281

2057

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.2

6.2

255

N05AF03

ATC

chlorprothixene; systemic

0.4

6.1

680

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.1

1636

14603

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.7

6.1

100

587

TQW80

NOMESCO Finland

Local dermatologic skincare

1.6

6.1

122

755

L03AA02

ATC

filgrastim; parenteral

0.5

6.1

941

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.1

436

3415

M06.1

ICD-10 Finland

Adult-onset Still disease

8.6

6.0

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.2

6.0

214

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.0

271

1980

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.4

6.0

254

1836

N03AG01

ATC

valproic acid; systemic, rectal

0.6

6.0

121

1903

-69

ICPC

Other reason for encounter NEC

1.5

6.0

173

1164

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011397) Hemoglobin [Presence] in Urine by Test strip

2611

12752

2.75

322.46

6.0

3.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1434

3923

4.40

307.65

3.9

2.7

10.00

10.60

g/l

5.95

1386

3567

(3017143) Hepatitis C virus Ab [Presence] in Serum

1631

5425

3.68

307.65

1.3

1.6

—

(3019069) Monocytes/100 leukocytes in Blood

5417

25344

7.75

307.65

15.7

5.8

9.14

8.51

50.76

5334

23608

(3021440) Promyelocytes/100 leukocytes in Blood

1622

4246

4.75

307.65

6.1

3.9

0.07

0.12

1.54

363

1347

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6064

42846

7.00

307.65

12.6

7.4

72.75

78.22

u/l

35.06

5999

40263

(3010144) Erythrocytes [#/volume] in Synovial fluid

391

421

9.82

307.65

1.7

1.3

22356.46

127536.17

e6/l

2.20

292

283

(3021601) Nitrite [Presence] in Urine by Test strip

4687

26820

3.66

307.65

7.6

4.9

0.00

estimate

0.80

1171

4893

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3184

9675

5.48

307.65

1.5

1.3

112.26

20.00

iu/ml

119.64

2368

2886

(3013115) Eosinophils [#/volume] in Blood

5949

27912

14.02

307.65

15.0

5.4

0.19

e9/l

1.70

5692

24317

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

440

408

11.49

307.65

1.8

1.4

35.52

28.69

2.30

291

240

(3037467) Urinalysis macro (dipstick) panel - Urine

5674

37859

4.86

307.65

8.4

4.3

—

(3015736) pH of Urine

3745

21553

2.73

307.65

5.4

3.4

5.77

5.86

0.71

130

1546

(3025159) Blasts/100 leukocytes in Blood

1588

4005

4.92

307.65

6.1

3.9

0.04

0.46

1.96

322

1111

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1780

6892

3.18

307.65

1.3

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1666

4467

4.67

307.65

6.0

3.9

0.64

0.94

3.79

410

1564

(3021788) Differential panel - Synovial fluid

749

824

10.14

307.65

1.7

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

992

1096

10.50

307.65

1.9

1.5

10702.29

12958.03

e6/l

0.70

788

766

(3018010) Neutrophils/100 leukocytes in Blood

5411

25627

7.56

307.65

14.9

5.4

57.76

57.07

4.59

5326

23891

(3006504) Eosinophils/100 leukocytes in Blood

5413

25195

7.79

307.65

15.1

5.5

2.82

2.84

0.21

5330

23416

(3013707) Erythrocyte sedimentation rate by Westergren method

6166

41166

10.29

307.65

12.7

3.8

15.02

12.43

mm/h

36.90

6085

37992

(3044941) Cell count panel - Synovial fluid

590

719

8.92

307.65

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3281

9097

6.25

307.65

1.5

1.2

109.50

2.59

u/ml

162.53

1696

3466

(3006315) Basophils [#/volume] in Blood

5932

26943

14.43

307.65

14.6

5.3

0.04

e9/l

17.09

5627

23059

(3022096) Basophils/100 leukocytes in Blood

5350

24382

7.68

307.65

15.2

5.5

0.79

0.68

47.08

5265

22604

(3009261) Glucose [Presence] in Urine by Test strip

4704

27108

3.65

307.65

6.0

3.7

0.00

estimate

1.57

1161

4817

(3002179) Metamyelocytes/100 leukocytes in Blood

1571

4067

4.77

307.65

5.3

3.8

0.36

0.67

6.95

362

1358

(3023420) DNA double strand Ab [Units/volume] in Serum

531

491

11.69

307.65

1.3

1.5

20.22

23.24

iu/ml

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3961

23532

2.74

307.65

2.6

2.2

78.96

78.47

nmol/l

0.49

3785

21080

(3002030) Lymphocytes/100 leukocytes in Blood

5423

25999

7.48

307.65

15.5

5.6

27.57

28.07

3.20

5342

24268

(3013650) Neutrophils [#/volume] in Blood by Automated count

6022

31487

13.06

307.65

18.1

8.6

3.97

4.05

e9/l

2.47

5728

27323

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

566

544

11.30

307.65

1.8

1.5

54.09

59.38

1.63

377

327

(3037522) Nuclear Ab [Titer] in Serum

2642

7324

5.39

307.65

1.4

1.3

493.64

555.80

titre

0.91

751

1562

(3021589) Normoblasts [#/volume] in Blood

4271

24013

3.26

307.65

17.6

9.0

0.00

e9/l

2.05

3875

19468

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1586

1325

15.50

307.65

1.6

9.07

6.07

iu/ml

0.12

369

259

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1061

1219

10.20

307.65

1.7

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1355

3464

4.68

307.65

1.2

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

4686

26784

3.67

307.65

6.0

3.7

0.00

estimate

0.13

1218

5233

(3019198) Lymphocytes [#/volume] in Blood

5938

27631

13.97

307.65

14.8

5.3

1.79

1.92

e9/l

12.12

5689

24255

(3001604) Monocytes [#/volume] in Blood

5927

26867

14.36

307.65

14.6

5.3

0.60

0.58

e9/l

8.88

5621

23020

(40760892) CBC W Ordered Manual Differential panel - Blood

5865

25201

14.30

307.65

14.0

5.8

—

(40758558) Short blood count panel - Blood

2649

13894

2.53

272.17

12.0

6.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

208

105

20.43

271.93

1.4

2.0

8.16

9.93

mg/l

1.82

154

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

186

25.84

267.37

1.3

1.7

74.51

144.98

au/ml

—

(3028026) IgM [Mass/volume] in Serum or Plasma

988

3113

3.56

258.40

1.8

1.9

1.21

1.40

g/l

2.69

927

2821

(3018095) Leukocytes [#/volume] in Urine

3220

19060

2.36

245.62

4.3

3.6

66.90

105.71

e6/l

1.73

2115

13339

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

661

1645

4.36

240.94

1.6

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

506

1013

5.33

240.17

4.1

3.6

57.13

57.67

0.38

506

1013

(3034891) Synovial lining cells/100 cells in Synovial fluid

241

205

12.17

238.63

1.6

1.4

3.84

5.03

0.34

(3015171) Extractable nuclear Ab [Units/volume] in Serum

772

2172

3.90

237.91

1.2

1.3

0.30

1.28

u/ml

3.30

212

(3029937) Albumin [Presence] in Urine by Test strip

2581

14395

2.31

219.80

7.5

4.0

0.00

estimate

1.70

1174

4768

(3026493) Urate [Moles/volume] in Serum or Plasma

2541

14162

2.30

215.85

2.3

2.5

1934.66

4582.82

umol/l

5.04

2308

12294

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

539

1407

4.09

183.02

1.2

1.3

—

(3017732) Neutrophils [#/volume] in Blood

960

3789

2.80

166.59

4.8

2.8

4.90

4.98

e9/l

0.05

768

3053

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3122

20648

1.98

154.14

7.0

3.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

395

956

4.33

147.82

1.1

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6259

54990

4.52

142.19

26.5

13.7

17.21

23.23

mg/l

67.27

5862

43350

(3024263) Appearance of Synovial fluid

188

239

8.07

138.34

2.0

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1527

8075

2.16

136.47

1.5

1.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

35.44

133.77

1.6

1.7

1.26

1.49

mg/l

0.32

(3042936) Bacteria identified in Isolate by Culture

1411

7442

2.14

125.70

2.3

2.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

464

1437

3.40

121.44

1.2

1.3

5.53

7.35

u/ml

0.32

245

(3013166) Neutrophils/100 leukocytes in Synovial fluid

138

140

10.05

120.97

1.7

1.2

48.17

58.12

1.73

128

116

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

458

1422

3.39

119.35

1.2

1.3

7.80

4.88

u/ml

0.29

157

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

482

1568

3.24

116.39

1.2

1.3

52.89

38.12

u/ml

0.43

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3758

27903

1.82

116.39

6.2

6.6

1.22

mmol/l

2.57

3240

23601

(3000850) Epithelial cells [#/volume] in Urine

1874

11292

1.93

113.37

2.7

2.6

5.10

6.19

e6/l

1.82

1728

10089

(3018418) pH of Serum or Plasma

2497

16638

1.81

108.78

3.4

4.0

7.40

0.97

494

3184

(3041096) Erythrocytes [Presence] in Urine by Automated

2227

14334

1.84

108.69

5.3

3.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

390

1168

3.49

107.35

1.2

11.07

15.46

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

388

1167

3.47

106.08

1.2

8.97

3.46

u/ml

0.78

(3045414) Leukocytes [Presence] in Urine

620

2478

2.66

102.62

2.3

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3410

25265

1.73

99.84

5.5

5.8

1.22

1.21

mmol/l

2.51

3233

22960

(3002582) Erythrocytes [#/volume] in Urine

2402

16251

1.76

96.27

3.5

3.2

55.27

75.75

e6/l

0.47

1969

12327

(3002385) Erythrocyte distribution width [Ratio]

5514

47361

2.07

96.07

29.2

16.4

15.35

15.01

4.44

5486

46512

(3030467) Casts [#/volume] in Urine by Automated count

2253

14979

1.77

95.88

3.5

3.1

0.37

0.44

e6/l

0.74

1831

11277

(3019150) Specific gravity of Urine by Refractometry

1851

11677

1.82

93.65

8.1

4.0

1.02

kg/l

1.75

224

1762

(36304419) Bacteria [Presence] in Urine

2188

14559

1.76

91.96

3.3

3.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2053

13542

1.75

88.17

2.5

2.2

3.37

2.94

mg/l

10.94

1847

11544

(3045424) Erythrocytes [Presence] in Urine

312

919

3.52

87.91

1.7

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

441

1606

2.87

86.92

1.6

0.22

0.24

g/l

5.49

418

1511

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

190

403

4.83

83.53

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

190

403

4.83

83.53

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

190

403

4.83

83.53

1.2

1.1

—

(40761535) Cells panel - Urine sediment

885

4503

2.12

83.53

6.8

3.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

189

400

4.84

83.31

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

189

400

4.84

83.31

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

445

1667

2.79

83.11

1.6

1.15

1.19

g/l

2.27

424

1569

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

189

401

4.82

83.06

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1496

9187

1.82

80.84

2.8

2.7

0.99

1.55

e6/l

1.04

1003

5138

(3023368) Bacteria identified in Blood by Culture

2076

14225

1.67

74.88

4.7

4.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

439

1723

2.66

74.72

2.7

2.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

851

4462

2.04

73.50

1.8

2.6

66.64

66.49

g/l

0.23

791

4053

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

339

1176

2.99

72.78

1.2

72.04

40.06

u/ml

2.32

132

(3007164) IgA [Mass/volume] in Serum or Plasma

1638

10605

1.73

72.56

1.6

1.4

2.76

2.40

g/l

9.97

1159

6299

(3004588) Protein electrophoresis panel - Serum or Plasma

738

3707

2.12

71.41

1.7

2.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1022

5808

1.90

69.58

2.7

2.4

1.84

1.80

0.66

921

5123

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

167

380

4.48

67.34

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

506

2249

2.36

65.85

1.3

1.6

7.36

15.02

u/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

233

693

3.45

64.57

1.2

1.3

47.45

53.03

u/ml

0.11

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

122

7.55

63.94

1.5

1.3

38.84

34.11

0.48

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

376

1527

2.55

59.48

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

279

988

2.91

57.62

1.7

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1306

8392

1.70

57.60

2.2

2.5

11.52

13.08

umol/l

11.56

1235

7827

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6261

58654

2.73

56.73

26.6

10.1

25.00

25.60

u/l

2.63

6222

56520

(3009871) Measles virus Ab [Titer] in Serum

152

6.19

54.37

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

214

679

3.22

53.45

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5741

52283

1.83

52.86

20.7

12.9

83.94

80.10

ml/min/173m2

42.77

5167

43189

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

252

902

2.87

51.01

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

447

2102

2.21

50.58

1.7

2.3

7.83

7.44

g/l

4.38

412

1896

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2097

2.21

50.48

1.7

2.3

4.01

3.63

g/l

7.63

411

1893

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2099

2.21

50.36

1.7

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

423

1973

2.22

48.80

1.6

2.3

3.21

2.94

g/l

6.05

388

1769

(3001729) Color of Synovial fluid

12.86

47.70

2.3

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

703

3.02

46.67

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

428

2043

2.17

46.58

2.0

1.23

2.01

ug/l

1.30

380

1809

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

300

1237

2.49

45.85

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

749

4380

1.80

45.20

1.9

2.5

71.86

69.84

e9/l

0.79

564

3291

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

201

682

3.01

44.80

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

945

5918

1.70

44.77

2.8

4.3

251.41

243.90

u/l

0.78

894

5584

(3004809) Band form neutrophils/100 leukocytes in Blood

234

864

2.77

44.68

2.7

3.3

1.18

1.51

0.69

214

772

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

350

1572

2.30

44.16

1.7

2.2

0.01

0.03

g/l

0.96

325

1435

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

1962

2.16

43.92

1.6

2.3

10.77

10.13

g/l

2.08

374

1739

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

381

1789

2.20

43.16

1.8

2.3

0.68

0.94

g/l

0.84

340

1543

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

285

1200

2.44

41.62

1.7

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

144

5.54

41.31

1.3

1.1

40.59

39.24

g/l

0.29

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

147

434

3.44

41.25

1.2

78.42

76.73

u/ml

0.02

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

375

1785

2.17

41.03

1.6

393.91

233.50

titre

0.48

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

147

437

3.42

40.81

1.2

57.35

34.71

u/ml

0.64

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

192

670

2.92

40.72

1.5

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

213

787

2.76

40.63

1.5

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

268

1111

2.47

40.48

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1250

8588

1.56

40.27

2.1

1.8

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

12.65

40.03

2.6

1.4

0.33

0.99

0.60

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1087

7246

1.60

39.83

2.3

2.5

19.93

22.56

8.65

933

6179

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

140

414

3.43

39.20

1.2

2.58

3.99

u/ml

—

(3007853) Bacteria identified in Skin by Aerobe culture

963

6277

1.63

38.60

2.0

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1141

7746

1.57

38.55

2.2

2.5

2.26

2.35

g/l

5.44

1077

7171

(3021960) Folate [Moles/volume] in Serum or Plasma

1719

12735

1.48

38.48

1.6

1.5

21.95

20.89

nmol/l

0.91

1492

10835

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

449

2341

1.99

38.43

1.4

1.7

1.62

1.56

g/l

0.60

382

2000

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1645

2.17

38.34

1.6

2.2

36.81

37.85

g/l

2.65

312

1435

(3008898) HLA-B27 [Presence]

368

1795

2.11

37.78

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

319

1478

2.22

37.31

1.6

2.2

0.00

g/l

-0.00

294

1347

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

905

5861

1.63

37.13

2.0

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

314

1453

2.22

36.83

1.6

2.3

0.00

g/l

-0.00

293

1344

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

219

877

2.55

35.60

1.9

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

306

1422

2.21

35.52

1.5

14.75

14.96

iu/ml

0.01

(3031040) Bacteria [#/volume] in Urine by Automated count

4199

36748

1.40

35.12

5.4

4.5

853.24

1521.08

e6/l

0.86

478

(3024561) Albumin [Mass/volume] in Serum or Plasma

2912

24015

1.38

34.79

4.2

4.7

34.43

35.56

g/l

21.50

2707

22274

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

208

849

2.50

32.50

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

208

849

2.50

32.50

1.6

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

881

5869

1.58

31.78

1.9

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

204

838

2.48

31.45

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2846

23691

1.36

30.65

2.9

2.8

134.15

122.30

ug/l

1.41

2674

21878

(3014051) Protein [Presence] in Urine by Test strip

297

1470

2.07

29.30

3.4

2.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

122

5.04

28.85

1.7

2.5

245.78

104.12

au/ml

0.98

(3017354) Segmented neutrophils/100 leukocytes in Blood

145

527

2.79

28.61

2.7

3.3

56.47

56.84

0.08

122

449

(3037756) Immunofixation for Serum or Plasma

238

1095

2.22

28.32

1.3

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

133

4.77

27.98

1.7

3.0

6.18

7.59

mg/l

0.71

105

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

152

573

2.69

27.97

1.3

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

152

573

2.69

27.97

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

193

821

2.39

27.60

2.5

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

176

4.18

27.47

1.1

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

148

573

2.62

25.86

2.9

3.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

141

549

2.60

24.37

1.9

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

318

1721

1.89

24.27

2.1

3.3

47.97

88.02

mg/l

0.63

271

1385

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

317

1721

1.89

23.96

2.0

3.3

35.75

51.94

mg/l

1.13

269

1387

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

309

1665

1.90

23.91

2.0

3.2

3.56

1.98

ratio

0.30

140

(3026782) Osmolality of Urine

1397

10726

1.38

23.72

3.1

2.9

523.60

526.96

mosm/kgh2o

0.22

1219

9169

(3022621) pH of Urine by Test strip

568

3644

1.61

23.69

4.2

3.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

132

506

2.64

23.56

1.9

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

214

1017

2.14

23.52

3.4

5.4

268.74

557.63

iu/ml

0.98

147

(3036481) Cortisol [Moles/volume] in Serum or Plasma

742

5088

1.52

23.05

1.8

2.2

347.22

374.55

nmol/l

3.09

695

4662

(3042631) Mycobacterium sp identified in Specimen

165

725

2.31

21.98

3.0

2.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1135

8532

1.40

21.63

3.2

2.9

2.61

2.99

e6/l

0.52

647

4512

(40761536) Microorganisms panel - Urine sediment

684

4671

1.52

21.60

5.0

4.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1317

10184

1.37

21.06

1.8

1.7

1160.84

1172.26

nmol/l

0.19

1063

7701

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

117

456

2.59

20.25

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

117

456

2.59

20.25

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

117

456

2.59

20.25

1.9

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

6279

60865

1.87

19.96

38.9

20.5

39.51

40.07

4.27

5983

56952

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.77

19.94

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

319

2.91

19.92

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

892

6519

1.43

19.82

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

133

557

2.42

19.79

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

122

492

2.51

19.69

4.0

3.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

147

3.90

19.68

1.2

—

(3007461) Platelets [#/volume] in Blood

6281

60917

1.87

19.54

39.1

20.4

265.42

254.02

e9/l

36.06

6214

59362

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1889

15540

1.30

19.48

3.0

2.9

1383.09

1262.42

ng/l

0.67

1674

13311

(3010813) Leukocytes [#/volume] in Blood

6282

60944

1.86

19.31

39.0

20.4

6.86

6.65

e9/l

12.48

6195

59202

(3035941) MCH [Entitic mass]

6281

60942

1.85

19.14

38.8

20.3

30.68

30.28

53.19

6252

60088

(3024731) MCV [Entitic volume]

6281

60942

1.85

19.14

38.8

20.3

93.01

91.10

174.97

6253

60089

(3026361) Erythrocytes [#/volume] in Blood

6281

60949

1.85

19.03

39.0

20.4

4.31

4.46

e12/l

122.39

6194

59218

(3024980) IgG subclass 4 [Mass/volume] in Serum

177

851

2.11

18.94

1.6

0.80

0.74

g/l

0.26

138

633

(3000963) Hemoglobin [Mass/volume] in Blood

6281

60962

1.84

18.83

39.2

20.5

131.34

134.30

g/l

60.34

6254

60116

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

569

3853

1.52

18.61

2.3

2.4

19.83

23.51

au/ml

0.45

292

(40760888) Immunoglobulin light chains.free panel - Serum

240

1298

1.88

18.40

2.0

3.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2910

25417

1.26

18.20

12.2

14.4

1.21

1.24

inr

1.34

934

7356

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

187

937

2.03

17.93

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

664

4677

1.47

17.88

3.3

3.7

1.23

mmol/l

1.61

611

4073

(3026008) Bacteria identified in Urine by Culture

2114

17817

1.28

17.66

3.5

3.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

828

6092

1.41

17.59

7.8

7.1

5.00

5.10

kpa

2.63

798

5806

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2014

16882

1.28

17.55

2.0

2.1

147.15

208.60

u/l

3.30

1906

15791

(3027801) Oxygen [Partial pressure] in Arterial blood

827

6090

1.41

17.47

7.8

7.1

11.80

12.43

kpa

2.84

795

5801

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

521

3509

1.53

17.46

1.2

1.3

51.15

54.80

au/ml

0.19

200

(3015377) Calcium [Moles/volume] in Serum or Plasma

2265

19278

1.27

17.38

2.5

3.4

2.34

2.36

mmol/l

6.73

2045

16874

(3016502) Oxygen saturation in Arterial blood

746

5414

1.43

17.10

8.1

7.5

94.88

95.76

2.65

723

5208

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

225

1222

1.87

17.05

1.3

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

282

2.86

16.87

1.7

1.5

—

(3011412) CD3 cells [#/volume] in Blood

117

499

2.37

16.78

2.3

2.4

0.96

1.21

e9/l

2.82

103

450

(3019060) Gas panel - Arterial blood

513

3482

1.51

16.56

4.7

5.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

535

2.30

16.43

1.4

1.3

6.93

6.75

g/l

0.16

362

(3003396) Base excess in Arterial blood by calculation

816

6080

1.39

16.02

7.9

7.1

1.23

1.10

mmol/l

0.46

677

4843

(3024139) IgG subclass 3 [Mass/volume] in Serum

121

535

2.29

16.00

1.4

1.3

0.45

0.41

g/l

0.36

363

(3028192) IgG subclass 2 [Mass/volume] in Serum

121

535

2.29

16.00

1.4

1.3

2.65

2.86

g/l

0.80

364

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

286

2.78

15.88

1.7

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

133

615

2.19

15.79

1.2

56.00

62.15

u/l

0.80

122

555

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2631

22962

1.24

15.77

2.0

92.79

96.93

pmol/l

4.34

1477

11505

(4062490) Immunoglobulin typing, IgG

120

536

2.26

15.50

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

252

1464

1.75

15.32

1.5

2.0

11.41

11.48

mg/l

0.04

229

1351

(3044927) Protein electrophoresis panel - Urine

119

534

2.25

15.21

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1305

10507

1.30

15.18

2.6

3.0

2.46

mmol/l

1.07

1158

9187

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

358

2.54

15.05

2.0

2.1

—

(3034770) Mitochondria Ab [Titer] in Serum

260

1539

1.72

14.80

1.2

1818.57

886.17

titre

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

438

6319

0.67

14.26

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

399

2.40

14.17

1.7

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3237

29087

1.22

14.14

5.2

6.2

9.78

11.03

umol/l

11.09

3093

27586

(1761868) Lipid panel - Serum or Plasma

1625

19196

0.80

13.70

2.6

2.9

—

(3028433) Virus identified in Specimen by Culture

162

3.23

13.63

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

458

3165

1.48

13.53

1.9

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

243

2.78

13.48

4.6

3.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

356

2336

1.55

13.43

1.4

2.0

37.00

39.59

u/l

1.56

312

2065

(3000330) Specific gravity of Urine by Test strip

406

2753

1.51

13.16

3.6

3.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

359

2.41

13.03

1.2

72.08

86.70

u/l

1.27

315

(3030981) Hyaline casts [#/volume] in Urine by Automated count

398

2702

1.50

12.83

2.8

2.7

0.15

0.29

e6/l

3.73

393

2622

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

546

3967

1.41

12.33

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

345

2.39

12.24

1.2

17.53

22.28

u/l

0.64

293

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

604

4478

1.38

12.10

3.1

2.5

67.90

65.42

ml/min/173m2

0.75

234

1771

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

384

2.31

12.10

2.0

2.1

19.63

15.65

2.24

373

(3006184) Hemoglobin [Mass/volume] in Capillary blood

200

1166

1.74

12.08

2.6

2.2

121.22

127.77

g/l

3.11

128

834

(3002173) Hemoglobin [Mass/volume] in Arterial blood

667

5038

1.36

11.90

8.8

7.9

117.90

120.93

g/l

3.50

652

4891

(1175426) CD3 cells/100 lymphocytes in Blood

394

2.28

11.85

2.0

2.1

72.46

72.55

0.02

375

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

238

2.66

11.78

1.2

1.1

—

(3017704) Immunofixation for Urine

292

2.48

11.66

1.2

1.6

—

(40761511) CBC panel - Blood by Automated count

5916

57259

1.36

11.37

20.0

13.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

339

2.35

11.32

1.3

21.68

11.76

u/l

3.47

309

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

333

2.33

10.85

2.6

0.20

0.22

e9/l

0.46

290

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

436

2.15

10.80

1.4

704.59

342.75

u/l

3.08

413

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

315

4595

0.67

10.77

1.5

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

347

2.29

10.75

2.5

376.60

539.82

e6/l

2.66

293

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

268

2.48

10.69

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

242

1534

1.60

10.65

1.1

1.2

110.00

150.14

titre

0.41

140

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

422

3008

1.43

10.61

1.6

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

189

3070

0.60

10.56

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

460

2.10

10.56

1.3

1.4

5.79

6.37

mmol/l

0.73

431

(3015235) Bicarbonate [Moles/volume] in Capillary blood

207

1272

1.65

10.34

2.9

3.1

24.82

24.97

mmol/l

0.24

202

1250

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2892

26193

1.19

10.23

2.6

2.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

280

2.41

10.22

2.9

2.7

45.66

41.38

0.97

159

(3003434) Protein [Mass/volume] in Pleural fluid

125

666

1.89

10.21

1.4

1.5

37.41

32.52

g/l

3.30

114

600

(3000012) Reticulocyte production index

134

733

1.85

10.09

1.6

2.2

—

(3012441) Differential panel - Pleural fluid

100

496

2.03

10.05

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

247

2.48

9.97

2.9

3.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

212

2.61

9.94

1.7

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

254

1658

1.55

9.88

3.0

3.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

373

2.19

9.88

1.7

1.5

6.26

6.45

u/l

0.04

308

(3037121) Protein [Mass/volume] in Urine

276

1841

1.52

9.73

2.6

3.0

0.30

g/l

0.04

121

702

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

388

2768

1.43

9.72

10.3

9.0

24.83

24.33

mmol/l

2.74

381

2689

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

787

1.80

9.67

2.0

2.5

508.22

1328.75

u/ml

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5887

57131

1.32

9.49

18.6

16.1

3.94

3.96

mmol/l

11.51

5750

55647

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1453

12422

1.22

9.49

1.7

1.53

1.17

mg/l

2.94

1181

9496

(3014007) Fractional oxyhemoglobin in Arterial blood

452

3327

1.39

9.46

9.9

8.7

93.13

94.00

1.67

447

3314

(3013826) Glucose [Moles/volume] in Serum or Plasma

3496

32301

1.18

9.44

4.9

4.5

6.63

6.68

mmol/l

0.67

3329

30202

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

540

1.94

9.22

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

2.71

9.22

1.6

2.3

220.78

18741.67

u/ml

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5871

56986

1.31

9.20

18.5

16.0

139.32

139.72

mmol/l

26.09

5750

55614

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

117

638

1.85

8.95

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

110

592

1.87

8.78

1.5

4432.55

1833.01

e6/l

1.03

431

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

115

2015

0.56

8.65

1.5

1.6

7.70

3.68

mg/l

1.46

1493

(3000093) Morphology [Interpretation] in Blood Narrative

485

1.95

8.52

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

445

3327

1.36

8.47

7.3

7.0

24.39

24.64

mmol/l

0.69

422

3159

(3016650) Hepatitis A virus Ab [Presence] in Serum

147

874

1.70

8.40

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

276

2.26

8.27

2.2

1.8

2.66

2.47

u/field

0.07

196

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

233

1560

1.51

8.13

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

533

1.87

7.93

1.5

1.4

41699.28

70513.47

e6/l

0.62

310

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

592

1.82

7.87

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

119

682

1.76

7.79

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

530

1.86

7.75

1.5

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

162

2.60

7.66

2.8

3.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

135

2.75

7.52

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

170

2.54

7.48

1.7

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

170

2.54

7.48

1.1

—

(3021901) Oxygen saturation in Capillary blood

149

921

1.63

7.39

2.9

2.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

220

2.33

7.36

1.1

1342.18

1511.65

miu/ml

0.53

220

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2292

20786

1.16

7.13

3.9

3.5

233.49

46.13

ng/l

0.48

1629

13968

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

140

2.65

7.04

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

262

1856

1.43

6.91

3.8

3.9

1.41

1.36

mmol/l

0.33

255

1826

(3014111) Lactate [Moles/volume] in Serum or Plasma

576

4601

1.28

6.85

8.0

6.7

1.30

1.33

mmol/l

0.27

570

4492

(3045788) Cell count panel - Pleural fluid

466

1.86

6.82

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

253

1789

1.43

6.75

1.8

2.3

900.30

643.34

ug/l

0.22

234

1680

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

132

2.66

6.71

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

180

2.40

6.67

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

331

2.00

6.58

1.1

—

(3017569) Oxygen content in Arterial blood

252

2.15

6.51

2.4

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

153

2.49

6.41

1.1

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

132

824

1.61

6.36

1.3

1.2

5.26

3.22

u/ml

0.50

255

(21494755) Public health laboratory ask at order entry panel

349

4565

0.75

6.24

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.96

6.10

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

416

3239

1.30

6.05

4.0

3.5

5.08

5.16

kpa

1.51

402

3076

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

274

0.18

6.01

5.4

16.8

1215.20

1479.63

nmol/l

—

269

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

304

2270

1.36

5.92

1.1

34.05

1.82

u/ml

—

(3000991) Gas panel - Venous blood

535

4313

1.26

5.91

9.0

8.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

267

0.19

5.87

5.0

12.0

550.80

840.71

nmol/l

—

255

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

263

2.06

5.87

1.2

1.1

12.75

28.50

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

278

2.02

5.79

2.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

278

2.02

5.79

2.4

1.8

—

(3009343) pH of Capillary blood

409

3198

1.30

5.78

4.0

3.5

7.43

7.42

0.72

407

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

429

1.80

5.66

1.1

1.2

96.07

178.82

titre

1.55

(3020891) Body temperature

281

2091

1.36

5.61

4.9

4.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3410

36089

0.88

5.61

2.9

3.1

50.20

47.06

u/l

1.01

3179

33496

(1616796) Gas panel - Central venous blood

170

1157

1.48

5.61

4.1

3.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.90

5.45

2.0

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

142

2.40

5.36

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

142

2.40

5.36

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

142

2.40

5.36

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

142

2.40

5.36

1.1

—

(3004451) EKG impression Narrative

253

2.02

5.31

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.18

5.31

1.2

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

187

2.20

5.30

2.7

2.4

—

(3035880) pH of Pleural fluid

281

1.97

5.28

1.2

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

151

2.32

5.15

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1207

10655

1.16

5.13

3.8

3.6

432.21

430.45

ng/l

0.00

976

8192

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

557

4589

1.23

5.09

2.7

2.8

212.01

178.20

ng/l

1.02

509

4174

(3005322) IgE [Units/volume] in Serum or Plasma

427

3415

1.27

5.08

1.3

164.30

189.12

u/ml

0.45

394

3143

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

390

3089

1.28

5.02

4.0

3.4

2.31

1.87

mmol/l

1.85

288

2321

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

252

1.99

5.01

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

252

1.99

5.01

1.1

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

123

802

1.54

5.01

1.3

1.2

4.43

4.50

u/ml

0.02

337

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

418

1.75

4.94

2.1

2.2

3.81

2.17

u/field

0.57

174

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

551

4550

1.23

4.94

2.3

5.80

7.05

ug/l

1.52

494

3963

(40767503) Oxygen content in Capillary blood by calculation

164

1142

1.45

4.86

3.0

2.5

15.02

16.11

3.16

565

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

106

674

1.58

4.83

7.6

6.4

11.97

11.70

mg/l

0.27

631

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1961

17995

1.13

4.65

3.3

3.2

33.69

34.93

u/l

0.24

1853

17048

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1208

0.60

4.60

2.0

3.7

81.43

29.84

u/ml

0.42

1179

(21494890) Protein electrophoresis panel - 24 hour Urine

550

1.63

4.58

1.2

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

122

2.38

4.55

1.2

835.50

419.76

ug/l

0.20

(3021447) Carbon dioxide [Partial pressure] in Venous blood

567

4737

1.22

4.55

3.4

3.7

5.74

5.83

kpa

1.47

547

4602

(3008536) Aspergillus sp Ab [Presence] in Serum

2.56

4.54

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

326

1.82

4.53

1.2

1.1

1.08

1.05

ratio

0.67

111

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1338

12009

1.14

4.47

1.6

1.7

23250239.10

33192615.84

pmol/l

0.33

1157

9918

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

554

1.61

4.46

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

269

2064

1.32

4.44

1.9

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

202

2.04

4.41

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

157

1107

1.43

4.39

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

157

1107

1.43

4.39

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

523

4353

1.22

4.36

2.9

3.6

75.78

87.54

ng/l

3.20

458

3721

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

217

2875

0.75

4.32

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1036

9165

1.16

4.24

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.49

4.24

1.1

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

362

2906

1.26

4.22

11.5

9.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1376

12419

1.14

4.20

1.2

1.3

1.23

1.69

u/ml

1.01

391

3350

(3002032) Base excess in Venous blood by calculation

561

4725

1.20

4.15

3.4

3.7

2.17

2.01

mmol/l

0.51

481

4037

(40768793) Breast Pathology biopsy report

105

1560

0.67

4.12

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.99

4.11

1.7

1.1

5.14

6.82

mmol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

264

1.86

4.11

2.3

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

662

5668

1.19

4.09

3.6

3.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

451

1.65

4.07

1.4

1.8

4.19

4.10

mg/l

0.06

433

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3525

33586

1.11

4.05

2.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

210

1.96

4.00

2.1

2.0

50.30

54.85

ug/l

0.32

205

(3001019) Free T4 and TSH panel - Serum or Plasma

214

2806

0.75

3.99

1.6

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5272

53969

0.88

3.98

4.0

4.6

5.79

5.92

mmol/l

10.72

4864

49182

(40768797) Stomach Pathology biopsy report

917

8079

1.16

3.96

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

214

2789

0.76

3.83

2.0

2.2

12.51

12.14

nmol/l

0.27

196

2450

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

200

1.96

3.81

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

130

912

1.43

3.80

1.1

1.2

311.22

286.73

u/ml

0.39

567

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

120

2.26

3.79

1.5

1.4

38.50

24.63

1.06

101

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

180

2.01

3.77

2.2

2.0

25.90

28.91

0.65

170

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

285

2256

1.28

3.77

2.3

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.57

3.71

1.2

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

108

1554

0.69

3.63

1.5

1.7

279.03

306.17

mu/l

0.44

1399

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

503

5924

0.84

3.62

1.5

1.7

1.49

1.45

0.62

451

5201

(4200892) Spirometry reversibility

484

4080

1.20

3.58

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

552

0.49

3.58

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

137

982

1.40

3.57

1.4

69.03

62.17

mmol/l

1.12

109

791

(3012501) Base excess in Blood by calculation

164

1213

1.36

3.54

4.6

4.1

2.43

2.64

mmol/l

0.58

122

831

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

164

2.02

3.53

1.4

1.5

8.33

8.63

ug/l

0.18

164

(3042111) Morphology [Interpretation] in Bone marrow Narrative

125

886

1.42

3.48

1.3

1.6

—

(3016038) Potassium [Moles/volume] in Urine

362

1.66

3.48

1.2

1.1

31.86

33.98

mmol/l

0.32

311

(3025941) Bacteria identified in Stool by Culture

372

3066

1.23

3.47

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

126

897

1.41

3.43

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

908

10170

0.88

3.40

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

468

1.57

3.33

1.1

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

182

1.93

3.32

2.4

2.0

5.32

10.24

3.02

168

(3033658) Prothrombin time (PT) actual/Normal

1535

14128

1.11

3.30

3.8

90.00

91.74

2.02

1490

13768

(3014133) Dog dander IgE Ab [Units/volume] in Serum

652

0.55

3.28

1.1

1.37

3.13

u/ml

1.30

286

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

718

1.44

3.17

2.7

2.1

25.33

22.63

mg/l

0.24

183

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

215

1.82

3.12

2.9

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

215

1.82

3.12

2.9

1.9

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.54

3.12

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

397

1.59

3.12

1.3

1.27

1.24

u/ml

0.01

221

(3019977) pH of Arterial blood

298

1.68

3.08

2.8

3.1

7.43

7.42

0.59

103

(3000060) B lymphocytes [#/volume] in Blood

125

2.08

3.07

2.0

27.14

171.59

e6/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

217

1.80

3.04

2.9

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

620

7074

0.86

3.04

4.1

4.6

35.06

32.73

5.54

479

4779

(3024354) Oxygen [Partial pressure] in Venous blood

455

3876

1.19

3.04

2.9

3.0

4.46

4.58

kpa

0.73

438

3752

(3027456) Digoxin [Moles/volume] in Serum or Plasma

137

1013

1.36

3.02

3.0

3.1

0.87

0.83

nmol/l

0.49

113

772

(3046861) Legionella sp Ag [Presence] in Urine

4.29

2.99

1.0

—

(4034850) Laboratory test

230

1832

1.26

2.97

13.6

9.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

950

0.65

2.94

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

949

0.65

2.92

1.4

—

(3010421) pH of Blood

184

1429

1.30

2.91

4.6

4.0

7.43

7.42

4.50

166

1304

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.32

2.90

1.9

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

947

0.65

2.90

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

945

0.65

2.87

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

332

3970

0.83

2.87

1.1

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

272

2220

1.24

2.84

5.9

5.3

1.76

1.62

0.86

255

2071

(3018677) aPTT in Platelet poor plasma by Coagulation assay

921

8309

1.13

2.80

1.9

2.1

29.43

29.70

0.57

891

8056

(3003458) Phosphate [Moles/volume] in Serum or Plasma

782

6986

1.14

2.78

4.4

5.6

1.03

mmol/l

0.20

739

6485

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

651

7345

0.87

2.73

2.9

3.1

0.76

0.78

ug/l

0.15

439

4985

(3011288) Drugs identified in Urine by Screen method

933

0.66

2.72

1.6

2.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1015

0.68

2.70

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

279

1.65

2.69

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.00

2.69

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

511

1.47

2.66

1.1

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

722

0.62

2.65

1.1

1.6

—

(3006270) Folate [Moles/volume] in Blood

479

1.49

2.64

1.2

1.1

300.52

363.55

nmol/l

2.04

409

(3014891) Appearance of Pleural fluid

2.33

2.64

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

298

1.62

2.58

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

345

0.46

2.56

1.1

—

(3019225) pH of Specimen

645

5726

1.14

2.54

4.2

4.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.73

2.54

1.0

95.86

5.56

iu/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

132

1726

0.76

2.54

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.50

2.52

1.0

—

(3000492) Spirometry study

596

5267

1.14

2.52

1.5

—

(3049717) Cytology report of Urine Cyto stain

236

1932

1.23

2.45

2.7

2.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

103

2.04

2.41

1.5

1.2

3.27

1.78

mmol/l

1.62

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

2.35

3.8

2.6

1.08

0.62

u/field

0.73

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.11

2.22

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.11

2.22

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

200

2443

0.81

2.21

1.3

34.52

32.83

iu/l

0.27

171

2119

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

114

1486

0.76

2.19

1.8

4.65

4.66

iu/l

0.01

544

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

113

860

1.32

2.16

1.8

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.00

2.14

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

791

0.68

2.14

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

814

0.69

2.13

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

330

1.52

2.13

1.5

1.6

5.23

6.39

u/l

1.06

283

(36660697) Celiac disease serology panel - Serum

507

4488

1.14

2.13

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

788

0.68

2.11

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.45

2.10

1.0

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

742

6729

1.12

2.09

1.9

2.2

147.88

133.86

ug/g

0.55

595

5271

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

127

987

1.29

2.09

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

595

0.64

2.09

1.1

0.56

3.41

u/ml

5.13

216

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

306

3571

0.85

2.08

3.0

3.8

63.00

56.29

u/ml

0.14

293

3432

(3038177) Helicobacter pylori Ab [Presence] in Serum

926

0.71

2.07

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1443

13520

1.09

2.07

2.4

2.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

127

989

1.29

2.07

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

110

1.91

2.05

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

103

1.94

2.04

1.3

1.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.40

2.02

1.0

1.1

8.80

3.25

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

576

1.38

2.02

3.0

5.0

7.05

7.33

mmol/l

0.28

480

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

185

1.68

2.00

1.3

1.5

45.67

65.05

1.83

152

(3023183) Ammonium ion [Moles/volume] in Plasma

1079

0.74

1.98

2.5

2.9

31.23

35.14

umol/l

0.97

976

(3007930) Methemoglobin/Hemoglobin.total in Blood

261

2210

1.19

1.97

6.0

5.4

0.86

0.90

0.62

245

2064

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

352

3057

1.16

1.95

2.5

2.4

—

(3020650) Glucose [Presence] in Urine

142

1.76

1.92

2.1

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

242

1.57

1.92

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

298

1.51

1.92

1.2

—

(3045142) Bone marrow Pathology biopsy report

616

1.35

1.91

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

174

1423

1.23

1.90

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

433

0.60

1.88

1.1

1.5

0.84

0.94

g/l

0.93

433

(3039000) Anion gap in Blood

153

1236

1.24

1.87

7.6

7.3

11.46

11.23

mmol/l

0.36

140

1100

(3026389) Candida sp identified in Specimen by Organism specific culture

108

836

1.30

1.87

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

181

2189

0.82

1.87

1.5

1.3

—

(3018572) Chloride [Moles/volume] in Blood

153

1237

1.24

1.86

7.6

7.3

104.99

105.22

mmol/l

0.24

140

1101

(1001926) Buprenorphine [Presence] in Urine by Screen method

1078

0.75

1.86

1.4

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

568

1.36

1.85

4.0

3.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.03

1.85

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

450

1.40

1.84

1.1

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1848

17555

1.07

1.84

2.4

2.6

61.35

63.48

u/l

0.17

1710

16158

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

112

875

1.28

1.82

1.2

1.4

135.93

118.37

u/ml

0.24

179

(3050129) First trimester maternal screen panel - Serum or Plasma

1141

0.76

1.81

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

517

4643

1.12

1.77

5.7

7.2

9.55

9.70

mmol/l

0.18

491

4426

(3028707) Methadone [Presence] in Urine by Screen method

618

0.68

1.76

1.5

2.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

533

0.65

1.74

1.0

1.1

0.40

0.24

u/ml

0.18

142

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.73

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

824

0.73

1.71

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

202

1.59

1.70

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

134

1081

1.24

1.69

2.0

2.8

—

(3022145) Colonoscopy Study observation

697

6384

1.10

1.67

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.89

1.64

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

265

0.53

1.63

1.1

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

221

1.54

1.61

1.4

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

162

1343

1.21

1.60

1.2

—

(3044889) 12 lead EKG panel

4007

39139

1.06

1.59

3.8

3.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

151

1.66

1.59

1.6

1.8

88.35

42.45

u/l

0.30

141

(3014765) Yersinia sp identified in Stool by Organism specific culture

190

1601

1.19

1.58

1.2

—

(40768443) Skin Pathology biopsy report

295

2577

1.15

1.57

1.2

—

(4146454) Self-monitoring of blood glucose

614

0.70

1.57

3.4

2.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

561

6161

0.90

1.57

3.2

4.0

23.84

25.37

ug/l

0.06

460

4941

(3025130) Human papilloma virus identified in Specimen

102

806

1.27

1.56

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

152

1.65

1.56

1.2

1.5

2.42

2.91

0.15

130

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

305

1.45

1.55

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

740

0.73

1.55

1.1

0.29

1.43

u/ml

4.07

342

(3015183) Erythrocyte sedimentation rate

256

1.49

1.54

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

107

1.78

1.54

1.3

1.5

117.24

127.40

ng/l

0.11

107

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

950

10174

0.92

1.53

3.8

4.3

21.00

21.81

1.05

462

5011

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

206

1754

1.18

1.53

3.0

0.36

0.34

u/ml

0.38

123

992

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1021

0.77

1.52

1.6

1.7

—

(3047181) Lactate [Moles/volume] in Blood

204

1738

1.18

1.51

6.7

6.3

1.50

1.27

mmol/l

1.44

181

1525

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.50

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

392

1.38

1.49

3.1

2.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

1.48

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.50

1.45

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.88

1.44

1.3

1.5

13.89

10.69

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

741

0.74

1.44

1.3

7.10

7.37

mmol/l

0.32

655

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.13

1.44

1.0

—

(3003338) MCHC [Mass/volume]

4702

46218

1.06

1.42

34.6

17.8

329.53

331.78

g/l

57.37

4676

45905

(3025577) Chromium [Mass/volume] in Blood

337

1.40

1.41

2.1

2.48

2.38

ug/l

0.08

286

(3010838) Calcium [Moles/time] in 24 hour Urine

132

1089

1.22

1.40

1.5

1.9

4.38

5.13

mmol/24h

2.07

113

962

(3026470) Cobalt [Mass/volume] in Blood

346

1.39

1.40

2.0

4.58

2.97

ug/l

1.44

315

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

380

1.37

1.40

1.5

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.18

1.39

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

250

0.56

1.38

2.1

2.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.94

1.36

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.83

1.35

1.6

1.3

0.40

1.67

mmol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

188

1609

1.17

1.35

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.87

1.34

1.4

1.3

27.38

477.52

u/l

—

(3002619) Bacteria identified in Specimen by Culture

105

1.72

1.32

1.4

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

111

906

1.23

1.32

2.0

2.6

64.62

63.37

0.26

111

901

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1203

12699

0.94

1.32

4.4

5.0

2.34

3.56

ug/l

1.94

1083

11362

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.32

0.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

1.3

5.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

185

1587

1.17

1.30

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

209

1.49

1.29

1.0

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

352

3158

1.12

1.29

3.3

3.1

123.94

128.65

g/l

3.77

344

3072

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

179

2084

0.85

1.29

3.0

3.4

372.89

2763.17

u/ml

1.04

150

1776

(3024928) Oxygen saturation in Venous blood

129

1073

1.21

1.29

2.2

2.9

—

(3022313) Gas panel - Capillary blood

265

2337

1.14

1.28

4.5

3.5

—

(3044640) Blood type and Crossmatch panel - Blood

1854

17805

1.06

1.27

2.5

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

268

0.60

1.27

2.1

99.00

149.90

ug/min

—

(4281824) Cell count and differential, peritoneal fluid

736

0.76

1.27

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

448

1.32

1.26

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.29

1.26

1.1

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

162

1.55

1.25

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

823

0.78

1.24

1.0

1.1

3.74

4.56

u/ml

0.19

393

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

923

0.79

1.23

1.1

0.74

1.83

u/ml

1.40

449

(3019832) Treponema pallidum Ab [Presence] in Serum

344

3820

0.89

1.23

1.5

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

108

1.67

1.22

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.63

1.21

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

207

1806

1.15

1.19

1.5

1.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.31

1.18

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

337

3735

0.90

1.18

2.6

3.3

4.28

4.45

pmol/l

2.44

298

3311

(3027273) Bicarbonate [Moles/volume] in Venous blood

278

2476

1.13

1.18

3.7

3.3

25.44

25.30

mmol/l

0.31

270

2400

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

165

1.52

1.17

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

1.58

1.17

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.15

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

1.15

0.0

7.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.33

1.12

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

788

0.78

1.12

1.0

1.1

0.56

1.11

u/ml

1.03

315

(3028300) Cannabinoids [Presence] in Urine

118

1401

0.84

1.11

1.4

2.0

—

(3047189) Immunofixation for 24 hour Urine

259

1.39

1.11

1.2

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.26

1.10

1.0

2.0

—

(4035726) Immunohistochemistry procedure

487

5277

0.92

1.09

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

1.49

1.09

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

372

1.32

1.09

1.2

1.5

81.33

80.23

umol/l

0.08

372

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

258

2302

1.13

1.08

4.5

3.9

49.38

48.15

0.37

253

2275

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

150

1289

1.17

1.08

1.3

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

172

1495

1.15

1.07

1.3

186.96

223.43

miu/ml

0.65

710

(3020876) Protein [Mass/time] in 24 hour Urine

586

1.25

1.06

2.1

2.3

0.75

1.39

g/24h

2.40

280

(3043410) Blood group antigens tested for on Red Blood Cells

137

1.53

1.05

2.1

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5531

54782

1.06

1.04

4.3

4.5

4.66

4.74

mmol/l

7.78

5190

50663

(3000764) Benzodiazepines [Presence] in Urine

118

1389

0.85

1.03

1.4

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

100

834

1.20

1.02

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.83

1.02

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

347

0.69

1.02

1.0

1.3

1.68

1.60

g/l

0.52

347

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1039

0.83

1.00

2.2

1.9

1.00

0.83

nmol/l

1.39

876

(3027008) Opiates [Presence] in Urine

119

1396

0.85

1.00

1.4

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5493

54412

1.06

0.99

4.2

4.4

1.59

1.51

mmol/l

35.32

5147

50018

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

504

0.75

0.97

1.1

1.5

3.81

3.84

ug/l

0.01

419

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

1.05

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.50

0.97

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

232

1.38

0.97

1.8

2.2

138.60

139.74

umol/l

0.01

128

(40758358) Immune stain study

0.00

0.96

0.0

1.0

—

(3016879) Cocaine [Presence] in Urine

109

1281

0.85

0.95

1.4

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5630

55825

1.06

0.95

4.7

5.0

2.67

2.80

mmol/l

22.50

5263

51365

(3027944) Amphetamines [Presence] in Urine

118

1377

0.85

0.95

1.4

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.77

0.94

1.2

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

234

0.64

0.94

1.5

1.3

2.51

4.12

umol/l

1.64

217

(40762814) Titanium [Mass/volume] in Blood

1.61

0.93

1.9

2.2

3.37

4.29

ug/l

—

(40768795) Lymph node Pathology biopsy report

597

1.23

0.93

1.2

—

(1002224) Polysomnography panel

185

2086

0.88

0.92

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.14

0.91

1.5

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

287

1.33

0.91

1.3

1.4

1.47

1.25

nmol/l

0.45

224

(3008116) Ketones [Moles/volume] in Urine by Test strip

102

1.57

0.90

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

519

1.24

0.89

2.3

2.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

103

0.49

0.89

1.0

1.1

83.08

52.19

u/ml

—

(3003129) Base excess in Capillary blood by calculation

135

1.48

0.89

2.3

1.7

1.82

0.77

mmol/l

0.45

127

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

596

0.79

0.88

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

380

0.74

0.86

1.0

350.43

335.18

ng/l

0.12

261

(3020682) Albumin/Creatinine [Ratio] in Urine

1652

17071

0.96

0.85

3.6

3.8

8.84

8.74

mg/mmol

0.03

1078

10449

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

614

0.80

0.84

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

154

1744

0.88

0.84

1.4

286.13

278.74

ug/g

0.21

1001

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.78

0.84

2.5

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

129

1.47

0.83

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4443

43854

1.04

0.82

4.1

4.2

15.13

14.78

pmol/l

16.35

4080

39941

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

507

1.23

0.82

2.3

2.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

160

1418

1.13

0.81

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

100

1163

0.86

0.80

1.3

14.94

12.86

u/l

0.67

958

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

267

1.31

0.80

1.1

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.73

0.79

1.1

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

775

1.18

0.79

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

374

1.26

0.79

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

114

1.49

0.79

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

135

1186

1.14

0.79

4.1

3.4

29.94

26.34

mg/l

0.57

726

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

193

2144

0.90

0.78

1.5

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

107

1.50

0.76

1.3

1.1

74.00

83.42

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

135

1528

0.88

0.75

1.4

280.05

164.25

pmol/l

0.55

130

1493

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.74

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

755

0.83

0.74

1.6

1.4

0.25

0.36

nmol/l

1.41

566

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

168

1506

1.12

0.73

1.3

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

223

2031

1.10

0.72

4.9

3.7

25.46

24.91

mmol/l

2.56

206

1865

(3034426) Prothrombin time (PT)

185

1.35

0.71

1.4

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.58

0.71

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

276

0.72

0.71

1.0

1.3

156.25

135.28

nmol/l

1.45

276

(21494434) Karyotype in Bone marrow

463

1.21

0.69

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

146

0.62

0.69

7.7

5.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.85

0.68

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.60

0.68

1.2

2.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5208

51645

1.04

0.68

4.8

5.0

1.97

2.09

mu/l

0.88

4806

47363

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

215

0.70

0.67

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

385

0.78

0.67

1.0

44.90

45.08

ng/l

0.01

259

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

384

0.78

0.66

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

285

2641

1.08

0.65

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.61

0.65

1.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

245

2656

0.92

0.64

1.7

—

(3024932) HLA-DR beta [Type]

154

0.65

0.64

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

459

1.20

0.64

1.3

1.83

1.50

nmol/l

1.04

418

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.72

0.64

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.72

0.64

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

198

1.31

0.63

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

382

0.78

0.63

1.0

842.35

711.55

ng/l

0.87

252

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

368

1.22

0.63

1.5

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

773

0.85

0.62

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

347

0.78

0.62

1.2

1.1

0.42

11.34

nmol/l

—

(3019174) dRVVT (LA screen)

1.63

0.62

1.3

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

434

0.81

0.60

1.0

297.67

291.04

mg/l

0.17

388

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

1.62

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

429

4050

1.06

0.60

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

371

1.21

0.60

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.59

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

1.34

0.59

2.4

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

157

1.34

0.59

2.4

3.3

—

(3009508) Creatinine [Moles/volume] in Urine

1669

17115

0.97

0.59

3.1

3.2

7.06

7.21

mmol/l

0.74

1440

14382

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

140

1.36

0.58

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

809

0.86

0.57

1.4

34.30

31.00

u/l

0.26

656

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

132

1189

1.11

0.57

1.2

1.3

22.78

25.49

e6/l

0.09

100

910

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

170

1552

1.10

0.57

2.4

4.08

3.57

g/l

3.12

164

1466

(3022493) Free Hemoglobin [Mass/volume] in Plasma

211

1.28

0.57

2.8

5.1

405.79

1007.15

mg/l

0.26

154

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

132

1190

1.11

0.56

1.2

3.78

3.77

mmol/l

0.03

123

1113

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

485

1.18

0.56

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

132

1192

1.11

0.55

1.3

1.4

2205.12

1258.27

e6/l

0.23

107

961

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

217

0.74

0.54

1.1

72.20

419.44

ng/l

—

(3024471) HLA-A [Type]

159

0.69

0.54

1.0

—

(3002256) Pathology report gross observation

725

7538

0.96

0.53

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

283

0.78

0.53

1.1

1.0

1.18

1.12

u/l

—

130

(40768446) Kidney Pathology biopsy report

196

1.28

0.52

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

193

2089

0.92

0.52

1.7

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

833

0.87

0.52

1.6

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

326

0.80

0.51

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

140

1536

0.91

0.51

1.6

2.1

7270.58

4883.42

u/l

0.28

620

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

109

1.38

0.50

1.3

103.73

110.37

0.25

103

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

144

1.32

0.50

1.1

288.64

315.44

pmol/l

0.17

105

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

247

0.77

0.50

1.1

1.4

149.58

201.47

pmol/l

0.63

247

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

745

0.87

0.50

1.1

1.82

3.12

u/ml

1.39

325

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

552

0.85

0.49

1.7

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.56

0.48

1.1

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5077

51114

0.97

0.48

5.3

5.7

38.33

39.69

mmol/mol

18.89

4772

47176

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

0.64

0.48

1.4

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

172

1.28

0.48

1.2

1.1

89.00

90.11

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

354

1.19

0.47

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

364

1.18

0.47

1.3

—

(3036180) Methadone [Presence] in Urine

165

0.73

0.46

1.4

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

118

0.68

0.45

1.6

2.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

1.32

0.45

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

120

1093

1.10

0.45

1.2

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.59

0.45

1.4

1.7

19.70

53.52

pmol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

175

0.74

0.44

1.6

2.1

—

(3012516) Albumin [Mass/volume] in Urine

1591

16248

0.97

0.44

3.2

688.71

398.49

mg/l

1.15

1068

9977

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.45

0.44

1.7

1.5

151.16

108.00

ug/l

—

(37021550) Renin [Units/volume] in Plasma --upright

130

1.31

0.43

1.1

1.3

26.98

78.35

mu/l

1.85

102

(3016018) Differential panel - Cerebral spinal fluid

573

1.14

0.43

1.2

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

734

1.12

0.43

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

734

1.12

0.43

1.3

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.41

0.43

1.1

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.61

0.43

1.0

1.5

260.40

335.61

umol/24h

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

716

1.12

0.42

1.2

1.3

299.93

347.98

pmol/l

0.51

616

(44816559) Phosphatidylethanol [Mass/volume] in Blood

934

0.90

0.42

1.4

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

122

1.31

0.42

1.1

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

140

1.29

0.41

1.1

1.0

—

(3044007) Cell count panel - Peritoneal fluid

158

1.27

0.41

1.6

2.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

316

0.82

0.41

1.2

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

316

0.82

0.41

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

737

1.11

0.41

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

737

1.11

0.41

1.3

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

608.31

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

475

4559

1.05

0.41

1.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.40

0.0

1.2

—

2.41

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

41.09

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

141

1524

0.92

0.40

1.0

1.1

3.36

6.35

u/ml

0.77

166

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

177

1.24

0.40

1.5

2.0

223.35

175.88

0.64

165

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

5.6

—

383.67

—

(3028717) Thiamine [Mass/volume] in Blood

1.31

0.39

1.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

105

0.67

0.39

7.3

7.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5279

52508

1.03

0.39

3.9

4.0

1.19

1.29

mmol/l

22.98

4920

47833

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

142

1.27

0.38

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.38

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.36

0.38

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

270

1.19

0.38

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

270

1.19

0.38

1.3

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

1.39

0.38

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

247

0.81

0.38

1.1

1.0

83.64

93.70

1.25

186

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

552

1.12

0.37

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

743

1.10

0.37

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

170

1.24

0.37

1.2

98.62

90.49

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

135

1253

1.08

0.36

2.2

2.3

79.11

85.84

ug/min

0.12

737

(3035637) Corticotropin [Mass/volume] in Plasma

693

0.89

0.36

1.2

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

309

1.17

0.36

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

592

1.12

0.36

1.2

1.1

96.54

95.36

0.13

557

(3011985) Renin [Units/volume] in Plasma

764

1.10

0.36

1.2

1.4

55.16

56.67

mu/l

0.03

676

(3020191) Ethanol [Moles/volume] in Serum or Plasma

385

0.86

0.35

1.2

1.6

1.67

1.18

promille

1.18

292

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

352

0.85

0.35

1.1

16.17

10.38

iu/ml

0.25

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.36

0.34

1.0

—

(40765096) Chromosome analysis panel by Banding

154

1.23

0.33

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.33

0.33

1.3

6.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.30

0.33

1.0

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.30

0.33

2.2

2.5

—

(3023410) Appearance of Cerebral spinal fluid

540

1.11

0.32

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

828

1.09

0.31

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

685

7036

0.97

0.31

8.0

6.7

—

(3035933) Granulocytes/100 leukocytes in Blood

138

1.23

0.30

1.9

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

754

1.09

0.30

1.3

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.27

0.30

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1514

14902

1.02

0.29

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

526

1.10

0.28

2.1

1.9

6.37

7.90

umol/l

0.52

368

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.27

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

748

1.08

0.27

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

129

1370

0.94

0.27

4.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.23

0.27

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

202

1927

1.05

0.27

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

128

0.78

0.26

1.5

2.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.30

0.26

1.3

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.67

0.25

2.4

5.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.20

0.25

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.72

0.24

1.3

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.71

0.24

1.0

0.21

4.29

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.71

0.24

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

542

1.09

0.24

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

275

1.13

0.23

1.8

1.5

7.69

8.18

mmol/l

0.45

263

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

541

5281

1.03

0.23

2.2

0.21

g/l

1.12

489

4936

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.19

0.22

1.1

0.07

1.48

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.77

0.22

1.3

2.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

768

1.07

0.21

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

3042.66

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

220

0.86

0.21

1.5

2.9

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

367

0.90

0.21

1.2

1.3

—

408.33

—

(3008607) Semen analysis panel

0.00

0.21

0.0

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

241

0.87

0.21

1.7

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.21

1.2

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.32

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

412

1.09

0.20

1.4

1.5

23.86

20.08

u/ml

—

(3034614) HLA Ag [Interpretation]

0.00

0.20

0.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

292

0.89

0.20

1.6

1.5

—

(3014271) Vancomycin [Susceptibility]

269

1.12

0.19

2.7

2.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

364

0.91

0.19

1.5

2.0

16.72

17.34

nmol/l

0.22

342

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

147

1533

0.96

0.18

2.2

2.3

209.73

193.27

1.16

140

1456

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

137

1.17

0.18

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.13

0.18

1.0

1.3

—

640.53

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

653

0.93

0.18

1.1

1.2

—

33.67

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

196

0.87

0.18

1.1

1.4

59.24

114.59

nmol/24h

0.98

196

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

560

0.93

0.18

3.6

4.9

38.65

82.94

u/ml

1.28

156

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

141

1352

1.04

0.18

1.2

1.3

914.75

524.05

mg/l

0.63

133

1274

(3015076) Soybean IgE Ab [Units/volume] in Serum

248

0.89

0.18

1.0

0.23

1.49

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

726

1.06

0.18

1.1

1.53

1.52

g/l

0.09

654

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

348

1.09

0.17

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.21

0.17

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

426

1.08

0.17

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.11

0.17

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.75

0.17

1.0

0.02

1.52

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

748

1.06

0.16

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

120

0.83

0.16

6.9

7.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

116

1211

0.96

0.16

2.7

3.3

266.21

613.42

u/ml

0.74

101

1100

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

350

1.09

0.16

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.75

0.15

6.0

6.9

—

(3000285) Sodium [Moles/volume] in Blood

1.14

0.15

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.13

0.15

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

379

0.92

0.15

1.1

39.70

40.02

mg/l

0.02

318

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

791

1.05

0.14

1.2

1.1

126.01

118.80

1.13

709

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.18

0.14

1.0

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

368

0.92

0.14

1.1

224.39

263.89

mg/l

0.94

322

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

388

0.93

0.14

5.0

6.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

442

4498

0.98

0.13

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

161

1660

0.97

0.13

2.0

2.1

92.47

92.46

0.00

151

1592

(3020874) Milk IgE Ab [Units/volume] in Serum

284

0.92

0.13

1.0

0.45

2.47

u/ml

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

735

0.95

0.13

1.6

2.4

270.36

2022.09

u/ml

0.73

722

(3012095) Magnesium [Moles/volume] in Serum or Plasma

908

8978

1.01

0.13

3.0

3.2

0.81

0.82

mmol/l

1.33

832

8395

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

107

0.84

0.13

1.0

—

(40757373) Influenza virus identified in Isolate

109

0.83

0.13

1.2

1.6

—

(3048879) Bone marrow aspiration report

161

1.12

0.13

1.8

2.0

—

(3012565) Volume of 24 hour Urine

283

0.92

0.12

1.7

2.3

2067.22

1915.88

0.26

255

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

382

3888

0.98

0.12

1.2

123.50

152.27

iu/ml

0.82

152

1463

(40768441) Liver Pathology biopsy report

433

1.06

0.12

1.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

210

1.10

0.12

1.2

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1528

15173

1.01

0.11

1.7

1.6

1.29

1.37

mmol/l

3.24

1305

12680

(3014599) Egg white IgE Ab [Units/volume] in Serum

281

0.92

0.11

1.0

0.37

0.69

u/ml

0.57

(3022689) Creatine [Moles/volume] in Urine

157

0.89

0.11

2.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

455

0.94

0.11

1.2

—

(3016750) Collection duration of Urine

299

1.07

0.10

1.8

2.1

513.74

494.02

min

0.38

217

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

173

1.10

0.10

1.4

2.1

795.13

18399.55

e6/l

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

218

0.92

0.10

1.3

1.4

30.55

29.89

umol/l

0.14

211

(3017509) Phencyclidine [Presence] in Urine

1.09

0.09

1.0

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

242

1.07

0.09

8.2

11.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

132

1354

0.97

0.09

2.4

3.0

1.63

1.54

mg/l

0.53

117

1241

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.11

0.09

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

194

1.08

0.09

1.6

2.3

463.31

754.72

e6/l

0.61

140

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

288

0.94

0.08

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

684

0.96

0.08

5.7

2.8

13.59

13.20

2.25

676

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.83

0.08

1.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

623

0.96

0.08

2.5

2.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.09

0.08

29.9

8.4

—

(40768804) Tissue Pathology biopsy report

2363

23718

0.99

0.08

2.0

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

645

6394

1.01

0.08

2.2

2.7

6.34

8.09

umol/l

2.26

548

5535

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.80

0.07

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

264

1.06

0.07

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

163

0.92

0.07

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

828

1.03

0.06

1.2

1.3

0.65

2.52

nmol/l

0.69

793

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.86

0.06

1.8

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

640

1.03

0.06

1.4

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.84

0.06

1.3

1.5

—

(3051651) Icteric interference index of Serum or Plasma

325

0.95

0.06

5.6

3.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

385

1.04

0.05

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

139

1.08

0.05

1.1

2.0

5.31

2.37

ug/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

150

1477

1.02

0.05

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

277

1.05

0.05

7.6

3.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

100

1.10

0.05

3.3

3.1

—

(3020491) Glucose [Moles/volume] in Blood

394

0.96

0.05

2.2

2.1

7.42

6.64

mmol/l

0.70

255

(3002079) Sodium [Moles/time] in 24 hour Urine

232

0.95

0.05

1.3

149.36

153.70

mmol/24h

0.09

232

(3033799) Differential panel - Peritoneal fluid

171

0.94

0.05

1.5

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

209

1.05

0.04

1.1

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

318

1.04

0.04

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

754

0.98

0.03

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

131

1.07

0.03

1.0

1.5

13.33

12.94

g/l

—

103

(3000034) Microalbumin [Mass/volume] in Urine

519

1.02

0.03

3.6

2.9

57.22

30.29

mg/l

0.69

376

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

219

0.96

0.03

1.2

1.5

—

1075877.27

iu/ml

—

(3008295) Osmolality of Serum or Plasma

580

1.02

0.02

1.4

273.18

277.13

mosm/kgh2o

0.79

451

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

351

1.03

0.02

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

133

1.05

0.01

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

530

5287

1.00

0.01

2.3

2.4

37.21

46.01

u/l

0.44

451

4496

(3013512) EKG study

1640

16413

1.00

0.01

3.8

3.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

737

0.99

0.01

1.8

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

126

0.95

0.00

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

165

1643

1.00

0.00

1.7

1.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

102

0.98

0.00

4.0

2.8

8692.30

1735.46

u/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

122

0.98

0.00

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

238

1.01

0.00

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

155

0.97

0.00

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

485

1.01

0.00

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

795

1.01

0.00

1.1

101.69

13390.14

iu/ml

0.53

175

(44813793) Dust mix specific IgE antibody measurement

384

0.99

0.00

1.1

—

(3004775) Volume in Urine collected for unspecified duration

414

0.99

0.00

1.8

2.2

738.75

626.53

0.65

270

(3036489) Thrombin time

202

2016

1.00

0.00

1.9

21.25

21.47

0.20

176

1754

(4094501) Cardiovascular stress test using bicycle ergometer

150

1501

1.00

0.00

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

6.8

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.23

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

65.38

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.80

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.91

0.00

1.0

1.2

11.00

10.02

mg/l

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

6.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

6.40

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.54

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.98

-0.00

1.3

2.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.97

-0.00

2.3

6.0

70.83

53.02

ug/min

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.97

-0.00

1.4

1.2

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1432.86

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.87

-0.00

5.8

12.2

5.82

5.42

mmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.00

-0.00

4.7

6.7

—

(3011648) Oxygen content in Venous blood

420

1.00

-0.00

1.9

2.0

11.13

11.11

0.01

420

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.94

-0.00

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.97

-0.00

1.4

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.99

-0.00

1.0

5.32

8.26

mg/g

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.88

-0.00

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.97

-0.00

1.4

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.97

-0.00

1.1

3.0

—

29.33

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.88

-0.00

5.8

3.7

32.67

42.34

umol/l

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint RHEUMA_SEROPOS_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
RHEUMA_SEROPOS_STRICT	1.267 [1.16, 1.38]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.474

During the follow-up period (1.1.1998 — 31.12.2019), 2802 out of 18091 females with RHEUMA_SEROPOS_STRICT died.

Males

Parameter	HR [95% CI]	p-value
RHEUMA_SEROPOS_STRICT	1.387 [1.26, 1.52]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 2121 out of 8553 males with RHEUMA_SEROPOS_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have RHEUMA_SEROPOS_STRICT.

N-year risk	Females	Males
1	0.099%	0.247%
5	0.74%	1.452%
10	2.046%	3.767%
15	3.95%	7.307%
20	6.912%	12.196%

Relationships between endpoints

↥

Index endpoint: RHEUMA_SEROPOS_STRICT – Seropositive rheumatoid arthritis, strict definition

GWS hits: 23

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Seropositive rheumatoid arthritis, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints